| Year |
Citation |
Score |
| 2025 |
Walmsley SL, Nabipoor M, Martel-Laferriere V, Loutfy M, Cooper C, Vachon ML, Boyachuk B, Aldebes P, Klein MB. Evaluation of the virtual care experience for persons in prospective cohorts with HIV during the COVID pandemic. Plos Digital Health. 4: e0000857. PMID 40354367 DOI: 10.1371/journal.pdig.0000857 |
0.395 |
|
| 2025 |
Young J, Wang S, Sacks-Davis R, Stewart A, van Santen DK, van der Valk M, Doyle JS, Matthews G, Berenguer J, Wittkop L, Lacombe K, Rauch A, Stoové M, Hellard M, Klein MB. Liver fibrosis regression in people living with HIV after successful treatment for hepatitis C. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 39972551 DOI: 10.1097/QAI.0000000000003646 |
0.373 |
|
| 2025 |
Chalouni M, Van Santen DK, Berenguer J, Jarrin I, Miro JM, Klein MB, Young J, Torgersen J, Rentsch CT, Gill MJ, Epstein RL, Linas B, Zangerle R, Surial B, Rauch A, et al. Time to direct-acting antivirals initiation and liver-related events in people with HIV and Hepatitis C virus. Aids (London, England). PMID 39970192 DOI: 10.1097/QAD.0000000000004161 |
0.494 |
|
| 2024 |
Marathe G, Moodie EE, Brouillette MJ, Delaunay CL, Cox J, Cooper C, Martel-Laferrière V, Hull M, Wong A, Walmsley S, Klein MB. Effect of depressive symptoms on health services utilization in the HIV and hepatitis C co-infected population in Canada. Aids Care. 1-7. PMID 39722438 DOI: 10.1080/09540121.2024.2432801 |
0.34 |
|
| 2024 |
Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, Leleux O, Merchadou L, van der Valk M, Smit C, Prins M, et al. Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort. Liver International : Official Journal of the International Association For the Study of the Liver. 45: 1-13. PMID 39656170 DOI: 10.1111/liv.16203 |
0.44 |
|
| 2024 |
Zhabokritsky A, Klein M, Harris M, Loutfy M, Guillemi S, Tan DHS, Falutz J, Andany N, Guaraldi G, Lovblom LE, Walmsley S. Prevalence and Correlates of Frailty Among Older Adults Living With HIV in the CHANGE HIV Cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 97: 226-231. PMID 39431506 DOI: 10.1097/QAI.0000000000003485 |
0.387 |
|
| 2024 |
Truscello E, Wang S, Young J, Sebastiani G, Walmsley SL, Hull M, Cooper C, Klein MB. Changes in hepatic steatosis before and after direct acting antiviral treatment in people living with HIV and Hepatitis C coinfection. The Journal of Infectious Diseases. PMID 39417816 DOI: 10.1093/infdis/jiae487 |
0.453 |
|
| 2024 |
Mboumba Bouassa RS, Needham J, Nohynek D, Samarani S, Bobeuf F, Del Balso L, Paisible N, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Singer J, Klein M, Lebouché B, Cox J, et al. Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028. Journal of Personalized Medicine. 14. PMID 39063999 DOI: 10.3390/jpm14070745 |
0.326 |
|
| 2024 |
Long C, Cinque F, Kablawi D, Kim DHD, Tadjo TF, Elgretli W, Ballesteros LR, Lupu A, Nudo M, Lebouché B, Kronfli N, Cox J, Costiniuk CT, De Pokomandy A, Routy JP, ... Klein MB, et al. Material deprivation is associated with liver stiffness and liver-related outcomes in people with HIV. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 39011563 DOI: 10.1111/liv.16022 |
0.336 |
|
| 2024 |
Arora AK, Vicente S, Engler K, Lessard D, Huerta E, Ishak J, Kronfli N, Routy JP, Cox J, Lemire B, Klein M, de Pokomandy A, Del Balso L, Sebastiani G, Vedel I, et al. Patient-reported outcomes and experiences of migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite treatment dispensation: the 'ASAP' study. Aids Research and Therapy. 21: 40. PMID 38890671 DOI: 10.1186/s12981-024-00632-5 |
0.364 |
|
| 2024 |
Saeed S, Thomas T, Dinh DA, Moodie E, Cox J, Cooper C, Gill J, Martel-Laferriere V, Panagiotoglou D, Walmsley S, Wong A, Klein MB. Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infectious Diseases. 11: ofae239. PMID 38798898 DOI: 10.1093/ofid/ofae239 |
0.461 |
|
| 2024 |
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, et al. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. The Lancet. Hiv. PMID 38224708 DOI: 10.1016/S2352-3018(23)00267-9 |
0.494 |
|
| 2024 |
Arora AK, Vicente S, Engler K, Lessard D, Huerta E, Ishak J, Routy JP, Klein M, Kronfli N, Cox J, Lemire B, de Pokomandy A, Del Balso L, Sebastiani G, Vedel I, et al. Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF: 'The ASAP study'. Hiv Medicine. PMID 38213087 DOI: 10.1111/hiv.13608 |
0.342 |
|
| 2024 |
Requena MB, Protopopescu C, Stewart AC, van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, et al. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019. The International Journal On Drug Policy. 124: 104311. PMID 38184902 DOI: 10.1016/j.drugpo.2023.104311 |
0.47 |
|
| 2023 |
van Santen DK, Stewart A, Doyle JS, Stoové MA, Asselin J, Klein MB, Young J, Berenguer J, Jarrin I, Lacombe K, Wittkop L, Leleux O, Salmon D, Bonnet F, Rauch A, et al. Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International Journal of Epidemiology. PMID 38066671 DOI: 10.1093/ije/dyad154 |
0.442 |
|
| 2023 |
Gobran ST, Pagliuzza A, Khedr O, Fert A, Chomont N, Bruneau J, Klein MB, Ancuta P, Shoukry NH. DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people. Journal of Virology. 97: e0110523. PMID 38051044 DOI: 10.1128/jvi.01105-23 |
0.506 |
|
| 2023 |
Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, et al. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration. The Lancet. Hiv. 10: e723-e732. PMID 37923486 DOI: 10.1016/S2352-3018(23)00233-3 |
0.375 |
|
| 2023 |
Davy-Mendez T, Napravnik S, Hogan BC, Eron JJ, Gebo KA, Althoff KN, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Rebeiro PF, Karris MY, Klein MB, Kitahata MM, Crane HM, et al. Hospital Readmissions among Persons with HIV in the United States and Canada, 2005-2018: A Collaboration of Cohort Studies. The Journal of Infectious Diseases. PMID 37697938 DOI: 10.1093/infdis/jiad396 |
0.319 |
|
| 2023 |
Kim J, Newcomb CW, Carbonari DM, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, et al. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016. Plos One. 18: e0290889. PMID 37656704 DOI: 10.1371/journal.pone.0290889 |
0.369 |
|
| 2023 |
Shengir M, Lebouche B, Elgretli W, Saeed S, Ramanakumar AV, Giannakis A, De Pokomandy A, Cox J, Costiniuk C, Routy JP, Klein MB, Sebastiani G. Switch to a raltegravir-based antiretroviral regimen in people with HIV and non-alcoholic fatty liver disease: A randomized controlled trial. Hiv Medicine. PMID 37641534 DOI: 10.1111/hiv.13531 |
0.309 |
|
| 2023 |
Cinque F, Saeed S, Kablawi D, Ramos Ballesteros L, Elgretli W, Moodie EEM, Price C, Monteith K, Cooper C, Walmsley SL, Pick N, Murray MCM, Cox J, Kronfli N, Costiniuk CT, ... ... Klein MB, et al. Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort. Bmj Open. 13: e076547. PMID 37607785 DOI: 10.1136/bmjopen-2023-076547 |
0.331 |
|
| 2023 |
Mboumba Bouassa RS, Comeau E, Alexandrova Y, Pagliuzza A, Yero A, Samarani S, Needham J, Singer J, Lee T, Bobeuf F, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Klein MB, et al. Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial. Cells. 12. PMID 37508476 DOI: 10.3390/cells12141811 |
0.304 |
|
| 2023 |
Shengir M, Fillebeen C, Wagner J, Ramanakumar AV, Kaouache M, Klein MB, Pantopoulos K, Sebastiani G. Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 37368933 DOI: 10.1097/QAI.0000000000003245 |
0.415 |
|
| 2023 |
Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, Rockstroh JK, Van Bremen K, Tsochatzis E, Mulay A, Price J, Garvey LJ, Lemoine M, Kablawi D, Lebouche B, ... Klein MB, et al. Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 37183550 DOI: 10.1111/liv.15605 |
0.332 |
|
| 2023 |
Lanièce Delaunay C, Klein MB, Godin A, Cox J, Kronfli N, Lebouché B, Doyle C, Maheu-Giroux M. Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. The International Journal On Drug Policy. 116: 104026. PMID 37075626 DOI: 10.1016/j.drugpo.2023.104026 |
0.357 |
|
| 2023 |
Isfordink CJ, Boyd A, Sacks-Davis R, van Santen DK, Smit C, Martinello M, Stoove M, Berenguer J, Wittkop L, Klein MB, Rauch A, Salmon D, Lacombe K, Stewart A, Schinkel J, et al. Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. The Lancet. Public Health. 8: e294-e304. PMID 36965984 DOI: 10.1016/S2468-2667(23)00056-7 |
0.435 |
|
| 2023 |
Klein MB. Living longer with HIV: gains for some but not for all. The Lancet. Hiv. PMID 36958366 DOI: 10.1016/S2352-3018(23)00060-7 |
0.395 |
|
| 2023 |
Young J, Wang S, Lanièce Delaunay C, Cooper CL, Cox J, Gill MJ, Hull M, Walmsley S, Wong A, Klein MB. The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination. The International Journal On Drug Policy. 114: 103981. PMID 36893502 DOI: 10.1016/j.drugpo.2023.103981 |
0.372 |
|
| 2023 |
Zhabokritsky A, Clarke R, Rosenes R, Smith G, Loutfy M, Andany N, Falutz J, Klein M, Harris M, Guillemi S, Tan DHS, Arbess G, Walmsley S. Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314. Viruses. 15. PMID 36851731 DOI: 10.3390/v15020517 |
0.325 |
|
| 2023 |
Sangaré MN, Baril JG, de Pokomandy A, Klein M, Thomas R, Tremblay C, Pexos C, Durand M, Chawla S, Laporte L, Trottier H. CD4/CD8 ratio outcome according to the class of the third active drug in antiretroviral therapy (ART) regimens: results from the Quebec Human Immunodeficiency Virus (HIV) Cohort Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36722329 DOI: 10.1093/cid/ciad056 |
0.31 |
|
| 2023 |
Royston L, Isnard S, Berini CA, Bu S, Lakatos PL, Bessissow T, Chomont N, Klein M, Lebouché B, de Pokomandy A, Kronfli N, Costiniuk CT, Thomas R, Tremblay C, Boivin G, et al. Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study. Bmj Open. 13: e067640. PMID 36690406 DOI: 10.1136/bmjopen-2022-067640 |
0.321 |
|
| 2023 |
Zalla LC, Cole SR, Eron JJ, Adimora AA, Vines AI, Althoff KN, Silverberg MJ, Horberg MA, Marconi VC, Coburn SB, Lang R, Williams EC, Gill MJ, Gebo KA, Klein M, et al. Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. Jama. 329: 52-62. PMID 36594946 DOI: 10.1001/jama.2022.23617 |
0.364 |
|
| 2022 |
Popovic N, Williams A, Périnet S, Campeau L, Yang Q, Zhang F, Yan P, Feld J, Janjua N, Klein M, Krajden M, Wong W, Cox J. National Hepatitis C estimates: Incidence, prevalence, undiagnosed proportion and treatment, Canada, 2019. Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada. 48: 540-549. PMID 38222827 DOI: 10.14745/ccdr.v48i1112a07 |
0.304 |
|
| 2022 |
van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, ... ... Klein MB, et al. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. Eclinicalmedicine. 56: 101810. PMID 36618902 DOI: 10.1016/j.eclinm.2022.101810 |
0.396 |
|
| 2022 |
Lodi S, Klein M, Rauch A, Epstein R, Wittkop L, Logan R, Rentsch CT, Justice AC, Touloumi G, Berenguer J, Jarrin I, Egger M, Puoti M, D'Arminio Monforte A, Gill J, et al. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection. Journal of the International Aids Society. 25: e26048. PMID 36562643 DOI: 10.1002/jia2.26048 |
0.43 |
|
| 2022 |
Lang R, Gill MJ, Coburn SB, Grossman J, Gebo KA, Horberg MA, Mayor AM, Silverberg MJ, Willig AL, Justice AC, Klein MB, Bosch RJ, Rabkin CS, Hogan B, Thorne JE, et al. The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007-2017. Aids (London, England). 37: 287-298. PMID 36541641 DOI: 10.1097/QAD.0000000000003423 |
0.363 |
|
| 2022 |
Klein MB, Young J, Ortiz-Paredes D, Wang S, Walmsley S, Wong A, Martel-Laferrière V, Pick N, Conway B, Angel J, Baril JG, Fraser C, Lebouché B, Tan DHS, Sandre R, et al. Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286). Patient Preference and Adherence. 16: 3267-3281. PMID 36536672 DOI: 10.2147/PPA.S379065 |
0.424 |
|
| 2022 |
Girometti N, Ogoina D, Tan DHS, Pozniak A, Klein MB. Intersecting HIV and mpox epidemics: more questions than answers. Journal of the International Aids Society. 25: e26043. PMID 36468930 DOI: 10.1002/jia2.26043 |
0.39 |
|
| 2022 |
McClean AR, Trigg J, Cardinal C, Loutfy M, Cooper C, Kroch A, Shokoohi M, Machouf N, Thomas R, Klein MB, Kelly DV, Wong A, Sanche S, Montaner JSG, Hogg RS. Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study. The Canadian Journal of Hospital Pharmacy. 75: 309-316. PMID 36246433 DOI: 10.4212/cjhp.3234 |
0.365 |
|
| 2022 |
Arora AK, Engler K, Lessard D, Kronfli N, Rodriguez-Cruz A, Huerta E, Lemire B, Routy JP, Wittmer R, Cox J, de Pokomandy A, Del Balso L, Klein M, Sebastiani G, Vedel I, et al. Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The 'ASAP' Study. Journal of Personalized Medicine. 12. PMID 36143282 DOI: 10.3390/jpm12091497 |
0.364 |
|
| 2022 |
Lang R, Humes E, Hogan B, Lee J, D'Agostino R, Massaro J, Kim A, Meigs JB, Borowsky L, He W, Lyass A, Cheng D, Kim HN, Klein MB, Cachay ER, et al. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection. Journal of the American Heart Association. e026473. PMID 36129038 DOI: 10.1161/JAHA.122.026473 |
0.334 |
|
| 2022 |
Ortiz-Paredes D, Amoako A, Lessard D, Engler K, Lebouché B, Klein MB. Barriers and facilitators related to HCV treatment uptake among HIV coinfected populations in Canada: Patient and treatment provider perceptions. Canadian Liver Journal. 5: 124-143. PMID 35991485 DOI: 10.3138/canlivj-2021-0020 |
0.415 |
|
| 2022 |
Ortiz-Paredes D, Amoako A, Lessard D, Engler K, Lebouché B, Klein MB. Potential interventions to support HCV treatment uptake among HIV co-infected people in Canada: Perceptions of patients and health care providers. Canadian Liver Journal. 5: 14-30. PMID 35990783 DOI: 10.3138/canlivj-2021-0021 |
0.392 |
|
| 2022 |
Marathe G, Moodie EEM, Brouillette MJ, Cox J, Cooper C, Delaunay CL, Conway B, Hull M, Martel-Laferrière V, Vachon ML, Walmsley S, Wong A, Klein MB. Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning. Bmc Medical Research Methodology. 22: 223. PMID 35962372 DOI: 10.1186/s12874-022-01700-y |
0.307 |
|
| 2022 |
Ortiz-Paredes D, Amoako A, Ekmekjian T, Engler K, Lebouché B, Klein MB. Interventions to Improve Uptake of Direct-Acting Antivirals for Hepatitis C Virus in Priority Populations: A Systematic Review. Frontiers in Public Health. 10: 877585. PMID 35812487 DOI: 10.3389/fpubh.2022.877585 |
0.302 |
|
| 2022 |
Marathe G, Moodie EE, Brouillette MJ, Delaunay CL, Cox J, Martel-Laferrière V, Gill J, Cooper C, Pick N, Vachon ML, Walmsley S, Klein MB. Impact of HCV cure on depressive symptoms in the HIV-HCV co-infected population in Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 35789253 DOI: 10.1093/cid/ciac540 |
0.401 |
|
| 2022 |
Lee JS, Humes E, Hogan BC, Justice AC, Klein M, Gebo K, John Gill M, Silverberg MJ, Rebeiro P, Horberg M, Karris M, Rabkin C, Moore RD, Althoff KN. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. The Lancet. Hiv. S2. PMID 35304844 DOI: 10.1016/S2352-3018(22)00067-4 |
0.349 |
|
| 2022 |
Lanièce Delaunay C, Maheu-Giroux M, Marathe G, Saeed S, Martel-Laferrière V, Cooper CL, Walmsley S, Cox J, Wong A, Klein MB. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada. The International Journal On Drug Policy. 103: 103627. PMID 35218989 DOI: 10.1016/j.drugpo.2022.103627 |
0.453 |
|
| 2022 |
Kim HN, Nance RM, Lo Re V, Silverberg MJ, Franco R, Sterling TR, Cachay ER, Horberg MA, Althoff KN, Justice AC, Moore RD, Klein M, Crane HM, Delaney JA, Kitahata MM. Development and Validation of a Model for Prediction of End-Stage Liver Disease in People With HIV. Journal of Acquired Immune Deficiency Syndromes (1999). 89: 396-404. PMID 35202048 DOI: 10.1097/QAI.0000000000002886 |
0.357 |
|
| 2022 |
Isnard S, Fombuena B, Ouyang J, Royston L, Lin J, Bu S, Sheehan N, Lakatos PL, Bessissow T, Chomont N, Klein M, Lebouché B, Costiniuk CT, Routy B, Marette A, et al. Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032). Bmj Open. 12: e053081. PMID 35039291 DOI: 10.1136/bmjopen-2021-053081 |
0.348 |
|
| 2021 |
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, et al. Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada. 6: 137-148. PMID 36341035 DOI: 10.3138/jammi-2020-0011 |
0.467 |
|
| 2021 |
McGinnis KA, Justice AC, Moore RD, Silverberg MJ, Althoff KN, Karris M, Lima VD, Crane HM, Horberg MA, Klein MB, Gange SJ, Gebo K, Mayor A, Tate JP, et al. Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34609485 DOI: 10.1093/cid/ciab883 |
0.349 |
|
| 2021 |
Lazarus JV, Safreed-Harmon K, Kamarulzaman A, Anderson J, Leite RB, Behrens G, Bekker LG, Bhagani S, Brown D, Brown G, Buchbinder S, Caceres C, Cahn PE, Carrieri P, Caswell G, ... ... Klein M, et al. Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV. Nature Communications. 12: 4450. PMID 34272399 DOI: 10.1038/s41467-021-24673-w |
0.361 |
|
| 2021 |
Lanièce Delaunay C, Godin A, Kronfli N, Panagiotoglou D, Cox J, Alary M, Klein MB, Maheu-Giroux M. Can hepatitis C elimination targets be sustained among people who inject drugs post-2030? The International Journal On Drug Policy. 103343. PMID 34215459 DOI: 10.1016/j.drugpo.2021.103343 |
0.353 |
|
| 2021 |
Palayew A, Schmidt AM, Saeed S, Cooper CL, Wong A, Martel-Laferrière V, Walmsley S, Cox J, Klein MB. Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada. Plos One. 16: e0249836. PMID 33872319 DOI: 10.1371/journal.pone.0249836 |
0.439 |
|
| 2021 |
Amoako A, Ortiz-Paredes D, Engler K, Lebouché B, Klein MB. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis. The International Journal On Drug Policy. 103247. PMID 33853727 DOI: 10.1016/j.drugpo.2021.103247 |
0.329 |
|
| 2021 |
Nina Kim H, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Rajender Reddy K, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, ... ... Klein MB, et al. Risk of Hepatocellular Carcinoma with Hepatitis B Viremia among HIV/Hepatitis B Virus-Coinfected Persons in North America. Hepatology (Baltimore, Md.). PMID 33780007 DOI: 10.1002/hep.31839 |
0.348 |
|
| 2021 |
Fehr D, Lebouché B, Ruppenthal L, Brownc M, Obasc N, Bourbonnière E, Girouard J, Massicotte A, Jenabian MA, Almomen AA, Frenette C, de Pokomandy A, Cox J, Giannakis A, Cheng M, ... ... Klein M, et al. Characterization of people living with HIV in a Montreal-based tertiary care center with COVID-19 during the first wave of the pandemic. Aids Care. 1-7. PMID 33779425 DOI: 10.1080/09540121.2021.1904500 |
0.36 |
|
| 2021 |
Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V, ... ... Klein M, et al. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. Jama Network Open. 4: e2037512. PMID 33595662 DOI: 10.1001/jamanetworkopen.2020.37512 |
0.359 |
|
| 2020 |
Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, van Duin D, Wohl DA, Hogan BC, Althoff KN, Gebo KA, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Mathews WC, Klein MB, et al. Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. The Journal of Infectious Diseases. PMID 33367842 DOI: 10.1093/infdis/jiaa786 |
0.311 |
|
| 2020 |
Sangaré MN, Baril JG, de Pokomandy A, Ferreira Guerra S, Carabali M, Laprise C, Thomas R, Klein M, Tremblay C, Roger M, Pexos C, Greenwald ZR, Machouf N, Durand M, Hardy I, et al. Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data. Open Forum Infectious Diseases. 7: ofaa404. PMID 33204746 DOI: 10.1093/Ofid/Ofaa404 |
0.433 |
|
| 2020 |
Rebeiro PF, Jenkins CA, Bian A, Lake JE, Bourgi K, Moore RD, Horberg MA, Matthews WC, Silverberg MJ, Thorne J, Mayor AM, Lima VD, Palella FJ, Saag MS, Althoff KN, ... ... Klein MB, et al. Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32936919 DOI: 10.1093/Cid/Ciaa1403 |
0.434 |
|
| 2020 |
Kronfli N, Dussault C, Chalifoux S, Kavoukian H, Klein MB, Cox J. A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada. The International Journal On Drug Policy. 85: 102921. PMID 32911319 DOI: 10.1016/J.Drugpo.2020.102921 |
0.4 |
|
| 2020 |
Young J, Wong S, Janjua NZ, Klein MB. Comparing direct acting antivirals for hepatitis C using observational data - Why and how? Pharmacology Research & Perspectives. 8: e00650. PMID 32894643 DOI: 10.1002/Prp2.650 |
0.397 |
|
| 2020 |
Lanièce Delaunay C, Cox J, Klein M, Lambert G, Grace D, Lachowsky NJ, Maheu-Giroux M. Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018). Sexually Transmitted Infections. PMID 32703845 DOI: 10.1136/Sextrans-2020-054464 |
0.417 |
|
| 2020 |
Kronfli N, Young J, Wang S, Cox J, Walmsley S, Hull M, Cooper C, Martel-Laferriere V, Wong A, Pick N, Klein MB. Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32504083 DOI: 10.1093/Cid/Ciaa702 |
0.52 |
|
| 2020 |
McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D, et al. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. PMID 32342504 DOI: 10.1002/Ijgo.13185 |
0.312 |
|
| 2020 |
Krahn T, Martel M, Sapir-Pichhadze R, Kronfli N, J F, G G, B L, Klein MB, Wong P, Deschenes M, Ghali P, Sebastiani G. Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients. The Journal of Infectious Diseases. PMID 32249283 DOI: 10.1093/Infdis/Jiaa170 |
0.44 |
|
| 2020 |
Kaufman E, de Castro C, Williamson T, Lessard B, Munoz M, Mayrand MH, Burchell AN, Klein MB, Charest L, Auger M, Marcus V, Coutlée F, de Pokomandy A. Acceptability of anal cancer screening tests for women living with HIV in the EVVA study. Current Oncology (Toronto, Ont.). 27: 19-26. PMID 32218656 DOI: 10.3747/Co.27.5401 |
0.342 |
|
| 2020 |
McClymont E, Ogilvie G, Albert A, Johnston A, Raboud J, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein MB, Harris M, Wobeser W, Bitnun A, et al. Impact of quadrivalent HPV vaccine dose spacing on immunologic response in women living with HIV. Vaccine. PMID 32147300 DOI: 10.1016/J.Vaccine.2020.02.075 |
0.339 |
|
| 2020 |
Aibibula W, Cox J, Hamelin AM, Klein MB, Brassard P. The Mediating Role of Depressive Symptoms in the Association Between Food Insecurity and HIV Related Health Outcomes Among HIV-HCV Co-Infected People. Aids and Behavior. PMID 31950306 DOI: 10.1007/S10461-020-02784-7 |
0.449 |
|
| 2019 |
Kronfli N, Linthwaite B, Sheehan N, Cox J, Hardy I, Lebouché B, de Pokomandy A, Frenette C, Roger M, Klein MB. Delayed linkage to HIV care among asylum seekers in Quebec, Canada. Bmc Public Health. 19: 1683. PMID 31842822 DOI: 10.1186/S12889-019-8052-Y |
0.479 |
|
| 2019 |
Merchante N, Saroli Palumbo C, Mazzola G, Pineda JA, Téllez F, Rivero-Juárez A, Ríos-Villegas MJ, Maurice JB, Westbrook RH, Judge R, Guaraldi G, Schepis F, Perazzo H, Rockstroh J, Boesecke C, ... Klein MB, et al. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31813962 DOI: 10.1093/Cid/Ciz1181 |
0.52 |
|
| 2019 |
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, et al. Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada? Bmc Infectious Diseases. 19: 982. PMID 31752729 DOI: 10.1186/S12879-019-4617-8 |
0.568 |
|
| 2019 |
Dore GJ, Feld JJ, Thompson A, Martinello M, Muir AJ, Agarwal K, Müllhaupt B, Wedemeyer H, Lacombe K, Matthews GV, Schultz M, Klein M, Hezode C, Estivill Mercade G, Kho D, et al. Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial. Journal of Hepatology. PMID 31655134 DOI: 10.1016/J.Jhep.2019.10.010 |
0.405 |
|
| 2019 |
Sebastiani G, Saeed S, Lebouche B, de Pokomandy A, Szabo J, Haraoui LP, Routy JP, Wong P, Deschenes M, Ghali P, Klein M. Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients. Aids (London, England). PMID 31651429 DOI: 10.1097/Qad.0000000000002412 |
0.496 |
|
| 2019 |
Yanes-Lane M, Dussault C, Linthwaite B, Cox J, Klein MB, Sebastiani G, Lebouché B, Kronfli N. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review. Journal of Viral Hepatitis. PMID 31638294 DOI: 10.1111/Jvh.13220 |
0.479 |
|
| 2019 |
Althoff KN, Chandran A, Zhang J, Arevalo WM, Gange SJ, Sterling TR, Gill MJ, Justice AC, Palella FJ, Rebeiro PF, Silverberg MJ, Mayor AM, Horberg MA, Thorne JE, Rabkin CS, ... ... Klein MB, et al. LIFE EXPECTANCY DISPARITIES AMONG ADULTS WITH HIV IN THE UNITED STATES AND CANADA: THE IMPACT OF A REDUCTION IN DRUG- AND ALCOHOL-RELATED DEATHS USING THE LIVES SAVED SIMULATION (LISSO) MODEL. American Journal of Epidemiology. PMID 31602475 DOI: 10.1093/Aje/Kwz232 |
0.312 |
|
| 2019 |
Poteat T, Hanna DB, Rebeiro PF, Klein M, Silverberg MJ, Eron JJ, Horberg MA, Kitahata MM, Mathews WC, Mattocks K, Mayor A, Rich AJ, Reisner S, Thorne J, Moore RD, et al. Characterizing the Human Immunodeficiency Virus Care Continuum Among Transgender Women and Cisgender Women and Men in Clinical Care: A Retrospective Time-series Analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31573601 DOI: 10.1093/Cid/Ciz322 |
0.386 |
|
| 2019 |
Pearce ME, Jongbloed K, Demerais L, MacDonald H, Christian WM, Sharma R, Pick N, Yoshida EM, Spittal PM, Klein MB. "Another thing to live for": Supporting HCV treatment and cure among Indigenous people impacted by substance use in Canadian cities. The International Journal On Drug Policy. 74: 52-61. PMID 31525640 DOI: 10.1016/J.Drugpo.2019.08.003 |
0.39 |
|
| 2019 |
Saeed S, Strumpf E, Moodie EEM, Wong L, Cox J, Walmsley S, Tyndall M, Cooper C, Conway B, Hull M, Martel-Laferriere V, Gill J, Wong A, Vachon ML, Klein MB, et al. Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake among People Living with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31504327 DOI: 10.1093/Cid/Ciz833 |
0.524 |
|
| 2019 |
Doyle MA, Lee T, Singer J, Crawley A, Klein M, Cooper C. Evaluation of Safety and Effectiveness of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Switch Followed by Ledipasvir/Sofosbuvir HCV Therapy in HIV-HCV Coinfection. Open Forum Infectious Diseases. 6. PMID 31363776 DOI: 10.1093/Ofid/Ofz318 |
0.53 |
|
| 2019 |
Klein MB. Hepatitis C virus elimination: time for disruptive innovation. Journal of the International Aids Society. 22: e25360. PMID 31347280 DOI: 10.1002/Jia2.25360 |
0.345 |
|
| 2019 |
de Ávila Machado MA, de Moura CS, Klein M, Winthrop K, Carleton B, Abrahamowicz M, Feld J, Curtis JR, Beauchamp ME, Bernatsky S. Direct-Acting Antivirals for Hepatitis C: Predictors of Early Discontinuation in the Real World. Journal of Managed Care & Specialty Pharmacy. 25: 697-704. PMID 31134863 DOI: 10.18553/Jmcp.2019.25.6.697 |
0.434 |
|
| 2019 |
Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, et al. Staying hepatitis C negative: a systematic review and meta-analysis of cure and reinfection in people who inject drugs. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31125496 DOI: 10.1111/Liv.14152 |
0.329 |
|
| 2019 |
Lo Re V, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, ... ... Klein MB, et al. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31107304 DOI: 10.1097/Qai.0000000000002094 |
0.494 |
|
| 2019 |
Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferrière V, Pick N, Klein MB. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up. Aids (London, England). 33: 1013-1022. PMID 30946155 DOI: 10.1097/Qad.0000000000002156 |
0.495 |
|
| 2019 |
Rossi C, Young J, Martel-Laferrière V, Walmsley S, Cooper C, Wong A, Gill MJ, Klein MB. Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV-Coinfected Patients in Clinical Care. Open Forum Infectious Diseases. 6: ofz055. PMID 30882016 DOI: 10.1093/ofid/ofz055 |
0.432 |
|
| 2019 |
Younger J, Raboud J, Szadkowski L, Harrigan R, Walmsley S, Bayoumi AM, Klein MB, Cooper C, Burchell AN, Loutfy M, Hull M, Wong A, Thomas R, Hogg R, Montaner J, et al. Tenofovir and emtricitabine resistance among antiretroviral-naive patients in the Canadian Observational Cohort Collaboration: implications for PrEP. Antiviral Therapy. PMID 30873953 DOI: 10.3851/Imp3302 |
0.359 |
|
| 2019 |
Althoff KN, Gebo KA, Moore RD, Boyd CM, Justice AC, Wong C, Lucas GM, Klein MB, Kitahata MM, Crane H, Silverberg MJ, Gill MJ, Mathews WC, Dubrow R, Horberg MA, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. The Lancet. Hiv. PMID 30683625 DOI: 10.1016/S2352-3018(18)30295-9 |
0.414 |
|
| 2019 |
Costiniuk CT, Saneei Z, Routy JP, Margolese S, Mandarino E, Singer J, Lebouché B, Cox J, Szabo J, Brouillette MJ, Klein MB, Chomont N, Jenabian MA. Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation. Bmj Open. 9: e024793. PMID 30659041 DOI: 10.1136/Bmjopen-2018-024793 |
0.478 |
|
| 2019 |
Kronfli N, Bhatnagar SR, Hull MW, Moodie EEM, Cox J, Walmsley S, Gill J, Cooper C, Martel-Laferriere V, Pick N, Klein MB. Trends in cause-specific mortality in HIV-Hepatitis C co-infection following hepatitis C treatment scale-up. Aids (London, England). PMID 30649045 DOI: 10.1097/QAD.0000000000002156 |
0.419 |
|
| 2019 |
Costiniuk CT, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Wasef D, Young J, de Castro C, Routy JP, Lebouché B, Cox J, Smith BM, Ambroise S, Pexos C, Patel M, ... ... Klein MB, et al. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study. Hiv Medicine. PMID 30620136 DOI: 10.1111/Hiv.12699 |
0.398 |
|
| 2019 |
Rebeiro PF, Jenkins C, Bian A, Lake J, Bourgi K, Horberg MA, Moore R, Altoff K, Klein M, Eron JJ, Gill MJ, Kitahata M, Napravnik S, Silverberg M, Mayor AM, et al. LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz415.2492 |
0.415 |
|
| 2019 |
Cocciolillo S, Malagoli A, Osikowicz M, Pembroke T, Deschenes M, Ghali M, Klein MB, Guaraldi G, Sebastiani G. SAT-286-Application of guidelines for fatty liver in two prospective cohorts of human immunodeficiency virus positive patients Journal of Hepatology. 70. DOI: 10.1016/S0618-8278(19)31518-X |
0.337 |
|
| 2018 |
Nitulescu R, Young J, Saeed S, Cooper C, Cox J, Martel-Laferriere V, Hull M, Walmsley S, Tyndall M, Wong A, Klein MB. Variation in hepatitis C virus treatment uptake between Canadian centres in the era of direct-acting antivirals. The International Journal On Drug Policy. 65: 41-49. PMID 30594080 DOI: 10.1016/J.Drugpo.2018.08.012 |
0.491 |
|
| 2018 |
Benmassaoud A, Nitulescu R, Pembroke T, Halme AS, Ghali P, Deschenes M, Wong P, Klein MB, Sebastiani G. Liver-related events in HIV-infected persons with occult cirrhosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30561558 DOI: 10.1093/Cid/Ciy1082 |
0.497 |
|
| 2018 |
Kronfli N, Nitulescu R, Cox J, Moodie EE, Wong A, Cooper C, Gill J, Walmsley S, Martel-Laferrière V, Hull MW, Klein MB. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada. Journal of the International Aids Society. 21: e25197. PMID 30460791 DOI: 10.1002/Jia2.25197 |
0.498 |
|
| 2018 |
Saeed S, Moodie EE, Strumpf E, Gill J, Wong A, Cooper C, Walmsley S, Hull M, Martel-Laferriere V, Klein MB. Real-World Impact of Direct Acting Antiviral Therapy on Health-Related Quality of Life in HIV/Hepatitis C Co-Infected Individuals. Journal of Viral Hepatitis. PMID 30141236 DOI: 10.1111/Jvh.12985 |
0.486 |
|
| 2018 |
Bekker LG, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, Dybul M, Eholie S, Esom K, Garnett G, Grimsrud A, Hakim J, Havlir D, Isbell MT, Johnson L, ... ... Klein M, et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission. Lancet (London, England). PMID 30032975 DOI: 10.1016/S0140-6736(18)31070-5 |
0.377 |
|
| 2018 |
McClymont E, Lee M, Raboud J, Coutlée F, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Harris M, Cohen J, Yudin MH, Wobeser W, Money D, et al. The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29985988 DOI: 10.1093/Cid/Ciy575 |
0.408 |
|
| 2018 |
Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, Smyth D, Feld JJ. The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 190: E677-E687. PMID 29866893 DOI: 10.1503/Cmaj.170453 |
0.382 |
|
| 2018 |
Palmer A, Gabler K, Rachlis B, Ding E, Chia J, Bacani N, Bayoumi AM, Closson K, Klein M, Cooper C, Burchell A, Walmsley S, Kaida A, Hogg R. Viral suppression and viral rebound among young adults living with HIV in Canada. Medicine. 97: e10562. PMID 29851775 DOI: 10.1097/Md.0000000000010562 |
0.425 |
|
| 2018 |
McLinden T, Moodie EEM, Harper S, Hamelin AM, Anema A, Aibibula W, Klein MB, Cox J. Injection drug use, food insecurity, and HIV-HCV co-infection: a longitudinal cohort analysis. Aids Care. 1-7. PMID 29716392 DOI: 10.1080/09540121.2018.1465171 |
0.465 |
|
| 2018 |
Kronfli N, Linthwaite B, Kouyoumdjian F, Klein MB, Lebouché B, Sebastiani G, Cox J. Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review. The International Journal On Drug Policy. 57: 95-103. PMID 29715590 DOI: 10.1016/J.Drugpo.2018.04.003 |
0.419 |
|
| 2018 |
Almeida-Brasil CC, Moodie EEM, Mclinden T, Hamelin AM, Walmsley SL, Rourke SB, Wong A, Klein MB, Cox J. Medication non-adherence, multi-tablet regimens, and food insecurity are key experiences in the pathway to incomplete HIV suppression. Aids (London, England). PMID 29683846 DOI: 10.1097/Qad.0000000000001822 |
0.377 |
|
| 2018 |
Sacks-Davis R, Doyle JS, Rauch A, Beguelin C, Pedrana AE, Matthews GV, Prins M, van der Valk M, Klein MB, Saeed S, Lacombe K, Chkhartishvili N, Altice FL, Hellard ME. Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era. Journal of the International Aids Society. 21: e25051. PMID 29633559 DOI: 10.1002/Jia2.25051 |
0.517 |
|
| 2018 |
Lacombe K, Klein MB. The Rocky Road to viral hepatitis elimination: assuring access to antiviral therapy for ALL coinfected patients from low- to high-income settings. Journal of the International Aids Society. 21: e25073. PMID 29633554 DOI: 10.1002/Jia2.25073 |
0.365 |
|
| 2018 |
Golizeh M, Melendez-Pena CE, Ward BJ, Saeed S, Santamaria C, Conway B, Cooper C, Klein MB, Ndao M. Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging. Plos One. 13: e0195148. PMID 29608613 DOI: 10.1371/Journal.Pone.0195148 |
0.519 |
|
| 2018 |
Costiniuk CT, Mehraj V, Routy JP, de Castro C, Wasef N, Jenabian MA, Salahuddin S, Lebouché B, Cox J, Szabo J, Klein M, Lands L, Shapiro AJ. Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study. Aids Research and Treatment. 2018: 7645125. PMID 29552357 DOI: 10.1155/2018/7645125 |
0.44 |
|
| 2018 |
McLinden T, Moodie EEM, Hamelin AM, Harper S, Rossi C, Walmsley SL, Rourke SB, Cooper C, Klein MB, Cox J. Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. Drug and Alcohol Dependence. 185: 374-380. PMID 29544189 DOI: 10.1016/J.Drugalcdep.2017.12.031 |
0.507 |
|
| 2018 |
Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, et al. Recent abacavir use increases risk for Types 1 and 2 myocardial infarctions among adults with HIV. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29419568 DOI: 10.1097/Qai.0000000000001642 |
0.386 |
|
| 2018 |
Benmassaoud A, Ghali P, Cox J, Wong P, Szabo J, Deschenes M, Osikowicz M, Lebouche B, Klein MB, Sebastiani G. Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. Plos One. 13: e0191985. PMID 29381754 DOI: 10.1371/Journal.Pone.0191985 |
0.523 |
|
| 2018 |
Aibibula W, Cox J, Hamelin AM, Moodie EEM, Anema A, Klein MB, Brassard P. Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people. Aids Care. 1-7. PMID 29374972 DOI: 10.1080/09540121.2018.1431385 |
0.549 |
|
| 2018 |
Rossi C, Saeed S, Cox J, Vachon ML, Martel-Laferrière V, Walmsley SL, Cooper C, Gill MJ, Hull M, Moodie EEM, Klein MB. Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients. Aids (London, England). PMID 29369156 DOI: 10.1097/Qad.0000000000001750 |
0.553 |
|
| 2018 |
Linthewaite B, Cox J, Klein M, Fallu J, Peiris H, Salahuddin S, Routy J, Lebouche B, Brouillette M, Szabo J, Giannakis A, Leblanc R, Jenabian M, Gilman S, Costiniuk C. Identifying smoking cessation targets for people living with HIV and HIV-HCV Journal of Virus Eradication. 4: 31-32. DOI: 10.1016/S2055-6640(20)30418-0 |
0.513 |
|
| 2018 |
Costiniuk C, Nitulescu R, Saneei Z, Wasef N, Salahuddin S, Castro CD, Wasef D, Lebouche B, Cox J, Smith B, Szabo J, Jenabian M, Bourbeau J, Klein M. Environmental and occupational exposures as predictors of airflow obstruction in an HIV tertiary care clinic Journal of Virus Eradication. 4: 10-11. DOI: 10.1016/S2055-6640(20)30375-7 |
0.405 |
|
| 2017 |
Maponga TG, Matteau Matsha R, Morin S, Scheibe A, Swan T, Andrieux-Meyer I, Spearman CW, Klein MB, Rockstroh JK. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. Hepatology, Medicine and Policy. 2: 8. PMID 30288321 DOI: 10.1186/s41124-017-0025-0 |
0.4 |
|
| 2017 |
Saeed S, Strumpf EC, Moodie EE, Young J, Nitulescu R, Cox J, Wong A, Walmsely S, Cooper C, Vachon ML, Martel-Laferriere V, Hull M, Conway B, Klein MB. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. Journal of the International Aids Society. 20. PMID 29116684 DOI: 10.1002/Jia2.25013 |
0.497 |
|
| 2017 |
Aibibula W, Cox J, Hamelin AM, Moodie E, Naimi AI, McLinden T, Klein MB, Brassard P. Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people. Hiv Medicine. PMID 29094807 DOI: 10.1111/Hiv.12561 |
0.552 |
|
| 2017 |
Aibibula W, Cox J, Hamelin AM, Moodie EEM, Naimi AI, McLinden T, Klein MB, Brassard P. Impact of Food Insecurity on Depressive Symptoms Among HIV-HCV Co-infected People. Aids and Behavior. PMID 29076031 DOI: 10.1007/S10461-017-1942-Z |
0.417 |
|
| 2017 |
de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, Burchell AN, Klein M, Charest L, Auger M, Rodrigues-Coutlée S, Coutlée F. The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV. The Journal of Infectious Diseases. 216: 447-456. PMID 28931234 DOI: 10.1093/Infdis/Jix273 |
0.346 |
|
| 2017 |
Grebely J, Dore GJ, Morin S, Rockstroh JK, Klein MB. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? Journal of the International Aids Society. 20: 1-8. PMID 28782335 DOI: 10.7448/Ias.20.1.22146 |
0.448 |
|
| 2017 |
McLinden T, Moodie EEM, Hamelin AM, Harper S, Walmsley SL, Paradis G, Aibibula W, Klein MB, Cox J. Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis. Aids and Behavior. PMID 28726043 DOI: 10.1007/S10461-017-1850-2 |
0.459 |
|
| 2017 |
Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Benson E, Rachlis A, ... ... Klein MB, et al. Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada. Canadian Journal of Public Health = Revue Canadienne De Sante Publique. 108: e169-e175. PMID 28621653 DOI: 10.17269/Cjph.108.5708 |
0.467 |
|
| 2017 |
Pembroke T, Deschenes M, Lebouché B, Benmassaoud A, Sewitch M, Ghali P, Wong P, Halme A, Vuille-Lessard E, Pexos C, Klein MB, Sebastiani G. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis. Journal of Hepatology. PMID 28527666 DOI: 10.1016/J.Jhep.2017.05.011 |
0.584 |
|
| 2017 |
Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB. A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. Plos One. 12: e0176282. PMID 28467457 DOI: 10.1371/Journal.Pone.0176282 |
0.54 |
|
| 2017 |
Patterson S, Jose S, Samji H, Cescon A, Ding E, Zhu J, Anderson J, Burchell AN, Cooper C, Hill T, Hull M, Klein MB, Loutfy M, Martin F, Machouf N, et al. A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada. Hiv Medicine. PMID 28440036 DOI: 10.1111/Hiv.12505 |
0.46 |
|
| 2017 |
Antoniou T, Szadkowski L, Walmsley S, Cooper C, Burchell AN, Bayoumi AM, Montaner JS, Loutfy M, Klein MB, Machouf N, Tsoukas C, Wong A, Hogg RS, Raboud J. Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients. Bmc Infectious Diseases. 17: 266. PMID 28399819 DOI: 10.1186/S12879-017-2379-8 |
0.439 |
|
| 2017 |
Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy. Bmc Infectious Diseases. 17: 246. PMID 28376824 DOI: 10.1186/S12879-017-2350-8 |
0.535 |
|
| 2017 |
Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB. Risk factors for hepatitis C virus reinfection after sustained virologic response in patients co-infected with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 28199495 DOI: 10.1093/Cid/Cix126 |
0.468 |
|
| 2017 |
Greenaway C, Azoulay L, Allard R, Cox J, Tran VA, Abou Chakra CN, Steele R, Klein M. A population-based study of chronic hepatitis C in immigrants and non-immigrants in Quebec, Canada. Bmc Infectious Diseases. 17: 140. PMID 28193199 DOI: 10.1186/S12879-017-2242-Y |
0.406 |
|
| 2017 |
Martel-Laferrière V, Nitulescu R, Cox J, Cooper C, Tyndall M, Rouleau D, Walmsley S, Wong L, Klein MB. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. Bmc Infectious Diseases. 17: 80. PMID 28095797 DOI: 10.1186/S12879-017-2196-0 |
0.482 |
|
| 2016 |
Marshall AD, Saeed S, Barrett L, Cooper CL, Treloar C, Bruneau J, Feld JJ, Gallagher L, Klein MB, Krajden M, Shoukry NH, Taylor LE, Grebely J. Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. Cmaj Open. 4: E605-E614. PMID 28018873 DOI: 10.9778/cmajo.20160008 |
0.328 |
|
| 2016 |
Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Rachlis A, Rourke S, ... ... Klein MB, et al. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada. Antiviral Therapy. PMID 27925609 DOI: 10.3851/Imp3114 |
0.497 |
|
| 2016 |
Gillis J, Loutfy M, Bayoumi AM, Antoniou T, Burchell AN, Walmsley S, Cooper C, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg R, Raboud J. A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 73: 531-539. PMID 27851713 DOI: 10.1097/Qai.0000000000001109 |
0.395 |
|
| 2016 |
van Buuren N, Fradette L, Grebely J, King A, Krajden M, MacParland SA, Marshall A, Saeed S, Wilson J, Klein MB, Sagan SM. The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C. Canadian Journal of Gastroenterology & Hepatology. 2016: 7603526. PMID 27843889 DOI: 10.1155/2016/7603526 |
0.424 |
|
| 2016 |
Aibibula W, Cox J, Hamelin AM, McLinden T, Klein MB, Brassard P. Association Between Food Insecurity and HIV Viral Suppression: A Systematic Review and Meta-Analysis. Aids and Behavior. PMID 27837425 DOI: 10.1007/S10461-016-1605-5 |
0.501 |
|
| 2016 |
Tanner Z, Lachowsky N, Ding E, Samji H, Hull M, Cescon A, Patterson S, Chia J, Leslie A, Raboud J, Loutfy M, Cooper C, Klein M, Machouf N, Tsoukas C, et al. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort. Bmc Infectious Diseases. 16: 590. PMID 27769246 DOI: 10.1186/S12879-016-1926-Z |
0.493 |
|
| 2016 |
Klein MB, Rockstroh JK, Wittkop L. Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection. Current Opinion in Hiv and Aids. 11: 521-526. PMID 27716732 DOI: 10.1097/Coh.0000000000000292 |
0.561 |
|
| 2016 |
Vuille-Lessard E, Lebouché B, Lennox L, Routy JP, Costiniuk CT, Pexos C, Giannakis A, Szabo J, Klein MB, Sebastiani G. nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV mono-infected patients. Aids (London, England). PMID 27603289 DOI: 10.1097/Qad.0000000000001241 |
0.5 |
|
| 2016 |
Money DM, Moses E, Blitz S, Vandriel SM, Lipsky N, Walmsley SL, Loutfy M, Trottier S, Smaill F, Yudin MH, Klein M, Harris M, Cohen J, Wobeser W, Bitnun A, et al. HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine. Vaccine. PMID 27544584 DOI: 10.1016/J.Vaccine.2016.08.016 |
0.406 |
|
| 2016 |
Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V, Kirk GD, Hull M, Kim HN, Sebastiani G, Moodie E, Silverberg MJ, Sterling TR, Thorne JE, Cescon A, et al. Risk of endstage liver disease in HIV-viral hepatitis co-infected persons in North America from the early to modern antiretroviral therapy eras. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27506682 DOI: 10.1093/Cid/Ciw531 |
0.545 |
|
| 2016 |
Kamstra R, Azoulay L, Steele R, Klein MB, Greenaway C. Hospitalizations in immigrants and non-immigrants diagnosed with chronic hepatitis C infection in Quebec. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27501843 DOI: 10.1093/Cid/Ciw540 |
0.402 |
|
| 2016 |
Hull M, Shafran S, Wong A, Tseng A, Giguère P, Barrett L, Haider S, Conway B, Klein M, Cooper C. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale. 2016: 4385643. PMID 27471521 DOI: 10.1155/2016/4385643 |
0.551 |
|
| 2016 |
Kesselring S, Cescon A, Colley G, Osborne C, Zhang W, Raboud JM, Hosein SR, Burchell AN, Cooper C, Klein MB, Loutfy M, Machouf N, Montaner J, Rachlis A, Tsoukas C, et al. Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy. Hiv Medicine. PMID 27385643 DOI: 10.1111/Hiv.12409 |
0.434 |
|
| 2016 |
Gjærde LI, Shepherd L, Jablonowska E, Lazzarin A, Rougemont M, Darling K, Battegay M, Braun D, Martel-Laferriere V, Lundgren JD, Rockstroh JK, Gill J, Rauch A, Mocroft A, Klein MB, et al. Trends in incidences and risk factors for hepatocellular carcinoma and other liver events in HIV and hepatitis C virus co-infected individuals from 2001 to 2014: a multi-cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27307505 DOI: 10.1093/Cid/Ciw380 |
0.523 |
|
| 2016 |
Aibibula W, Cox J, Hamelin AM, Mamiya H, Klein MB, Brassard P. Food insecurity and low CD4 count among HIV-infected people: a systematic review and meta-analysis. Aids Care. 1-9. PMID 27306865 DOI: 10.1080/09540121.2016.1191613 |
0.351 |
|
| 2016 |
Costiniuk CT, Brunet L, Rollet-Kurhajec KC, Cooper CL, Walmsley SL, Gill MJ, Martel-Laferriere V, Klein MB. Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis. Open Forum Infectious Diseases. 3: ofw050. PMID 27047987 DOI: 10.1093/Ofid/Ofw050 |
0.47 |
|
| 2016 |
Moqueet N, Cooper C, Gill J, Hull M, Platt RW, Klein MB. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection. The Journal of Infectious Diseases. PMID 26984148 DOI: 10.1093/Infdis/Jiw088 |
0.52 |
|
| 2016 |
Cox J, Hamelin AM, McLinden T, Moodie EE, Anema A, Rollet-Kurhajec KC, Paradis G, Rourke SB, Walmsley SL, Klein MB. Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities. Aids and Behavior. PMID 26912217 DOI: 10.1007/S10461-016-1326-9 |
0.53 |
|
| 2016 |
Rossi C, Cox J, Cooper C, Martel-Laferrière V, Walmsley S, Gill J, Sapir-Pichhadze R, Moodie EE, Klein MB. Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV co-infected patients. Aids (London, England). PMID 26859371 DOI: 10.1097/Qad.0000000000001060 |
0.464 |
|
| 2016 |
Saeed S, Strumpf EC, Walmsley S, Rollet-Kurhajec K, Pick N, Martel-Laferriere V, Hull M, Gill MJ, Cox J, Cooper C, Klein MB. How generalizable are the results from trials of Direct Antiviral Agents to people coinfected with HIV/Hepatitis C virus in the real world? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26743093 DOI: 10.1093/Cid/Civ1222 |
0.502 |
|
| 2016 |
May MT, Gill MJ, Wittkop L, Klein M, Sabin C, Harrigan PR, Dunn D, Vehreschild JJ, Rubio R, Mocroft A, Cavassini M, et al. Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. Aids (London, England). 30: 503-13. PMID 26562844 DOI: 10.1097/Qad.0000000000000941 |
0.524 |
|
| 2015 |
Mojaverian N, Moodie EE, Bliu A, Klein MB. The Impact of Sparse Follow-up on Marginal Structural Models for Time-to-Event Data. American Journal of Epidemiology. PMID 26589708 DOI: 10.1093/Aje/Kwv152 |
0.347 |
|
| 2015 |
Greenaway C, Thu Ma A, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I. The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. Plos One. 10: e0141715. PMID 26558905 DOI: 10.1371/Journal.Pone.0141715 |
0.416 |
|
| 2015 |
Gillis J, Bayoumi AM, Burchell AN, Cooper C, Klein MB, Loutfy M, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Raboud J. Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study. Bmc Infectious Diseases. 15: 453. PMID 26496954 DOI: 10.1186/S12879-015-1206-3 |
0.43 |
|
| 2015 |
Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, Loutfy MR, Cooper C, Burchell AN, Palmer AK, Tsoukas C, Machouf N, Klein MB, Rourke SB, Rachlis A, et al. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care. Journal of the International Aids Society. 18: 20024. PMID 26443752 DOI: 10.7448/Ias.18.1.20024 |
0.471 |
|
| 2015 |
Jenabian MA, Mehraj V, Costiniuk CT, Vyboh K, Kema I, Rollet K, Ramirez RP, Klein MB, Routy JP. Influence of Hepatitis C Virus (HCV) sustained virological response on immunosuppressive Tryptophan catabolism in ART-treated HIV/HCV co-infected patients. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 26436613 DOI: 10.1097/Qai.0000000000000859 |
0.578 |
|
| 2015 |
Brunet L, Moodie EE, Young J, Cox J, Hull M, Cooper C, Walmsley S, Martel-Laferrière V, Rachlis A, Klein MB. Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C-Coinfected Persons. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26400998 DOI: 10.1093/Cid/Civ838 |
0.535 |
|
| 2015 |
Koethe JR, Jenkins CA, Lau B, Shepherd BE, Justice AC, Tate JP, Buchacz K, Napravnik S, Mayor AM, Horberg MA, Blashill AJ, Willig A, Wester CW, Silverberg MJ, Gill J, ... ... Klein M, et al. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada. Aids Research and Human Retroviruses. PMID 26352511 DOI: 10.1089/Aid.2015.0147 |
0.429 |
|
| 2015 |
Young J, Mucsi I, Rollet-Kurhajec KC, Klein MB. Fibroblast growth factor 23: associations with antiretroviral therapy in patients co-infected with HIV and hepatitis C. Hiv Medicine. PMID 26307135 DOI: 10.1111/Hiv.12305 |
0.499 |
|
| 2015 |
Lo Re V, Kallan MJ, Tate JP, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park LS, Dubrow R, Reddy KR, Kostman JR, et al. Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients. Open Forum Infectious Diseases. 2: ofv109. PMID 26284259 DOI: 10.1093/Ofid/Ofv109 |
0.548 |
|
| 2015 |
Peters L, Klein MB. Epidemiology of hepatitis C virus in HIV-infected patients. Current Opinion in Hiv and Aids. 10: 297-302. PMID 26248117 DOI: 10.1097/Coh.0000000000000183 |
0.565 |
|
| 2015 |
Patterson S, Cescon A, Samji H, Chan K, Zhang W, Raboud J, Burchell AN, Cooper C, Klein MB, Rourke SB, Loutfy MR, Machouf N, Montaner JS, Tsoukas C, Hogg RS, et al. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada. Bmc Infectious Diseases. 15: 274. PMID 26183704 DOI: 10.1186/S12879-015-0969-X |
0.461 |
|
| 2015 |
Brunet L, Moodie E, Cox J, Gill J, Cooper C, Walmsley S, Rachlis A, Hull M, Klein MB. Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada. Hiv Medicine. PMID 26140381 DOI: 10.1111/Hiv.12279 |
0.38 |
|
| 2015 |
Rollet-Kurhajec KC, Moodie EE, Walmsley S, Cooper C, Pick N, Klein MB. Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection - The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index. Plos One. 10: e0129868. PMID 26090666 DOI: 10.1371/Journal.Pone.0129868 |
0.555 |
|
| 2015 |
Sebastiani G, Rollet-Kurhajec KC, Pexos C, Gilmore N, Klein MB. Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunodeficiency virus mono-infected patients. Open Forum Infectious Diseases. 2: ofv015. PMID 26034765 DOI: 10.1093/Ofid/Ofv015 |
0.466 |
|
| 2015 |
Yeung MW, Young J, Moodie E, Rollet-Kurhajec KC, Schwartzman K, Greenaway C, Cooper C, Cox J, Gill J, Hull M, Walmsley S, Klein MB. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study. Hiv Clinical Trials. 16: 100-10. PMID 25972048 DOI: 10.1179/501100000024 |
0.499 |
|
| 2015 |
Young J, Xiao Y, Moodie EE, Abrahamowicz M, Klein MB, Bernasconi E, Schmid P, Calmy A, Cavassini M, Cusini A, Weber R, Bucher HC. Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 413-21. PMID 25932884 DOI: 10.1097/Qai.0000000000000662 |
0.386 |
|
| 2015 |
Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals. International Journal of Molecular Sciences. 16: 6496-512. PMID 25803108 DOI: 10.3390/Ijms16036496 |
0.396 |
|
| 2015 |
Kitahata MM, Drozd DR, Crane HM, Van Rompaey SE, Althoff KN, Gange SJ, Klein MB, Lucas GM, Abraham AG, Lo Re V, McReynolds J, Lober WB, Mendes A, Modur SP, Jing Y, et al. Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and design. Aids Research and Treatment. 2015: 923194. PMID 25789171 DOI: 10.1155/2015/923194 |
0.404 |
|
| 2015 |
Butt AA, Yan P, Lo Re V, Rimland D, Goetz MB, Leaf D, Freiberg MS, Klein MB, Justice AC, Sherman KE. Liver fibrosis progression in hepatitis C virus infection after seroconversion. Jama Internal Medicine. 175: 178-85. PMID 25485735 DOI: 10.1001/Jamainternmed.2014.6502 |
0.446 |
|
| 2015 |
Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, Bosch RJ, Crane H, Eron J, Gill MJ, Horberg MA, Justice AC, Klein M, Mayor AM, Moore RD, et al. End-stage renal disease among HIV-infected adults in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 60: 941-9. PMID 25409471 DOI: 10.1093/Cid/Ciu919 |
0.496 |
|
| 2015 |
Samji H, Taha TE, Moore D, Burchell AN, Cescon A, Cooper C, Raboud JM, Klein MB, Loutfy MR, Machouf N, Tsoukas CM, Montaner JS, Hogg RS. Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada. Hiv Medicine. 16: 76-87. PMID 25174373 DOI: 10.1111/Hiv.12173 |
0.479 |
|
| 2015 |
Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients. Hiv Medicine. 16: 24-31. PMID 24837567 DOI: 10.1111/Hiv.12168 |
0.569 |
|
| 2015 |
Christina G, Ma AT, Kloda LA, Klein MB, Cnossen S, Schwarzer G, Shrier I. 811 The Seroprevalence of Hepatitis C in Immigrants and Refugees From Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)33411-9 |
0.305 |
|
| 2014 |
Hull M, Shafran S, Tseng A, Giguère P, Klein MB, Cooper C. CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 25: 311-20. PMID 25587293 DOI: 10.1155/2014/251989 |
0.568 |
|
| 2014 |
Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU, Mocroft A, Hogg RS, et al. The effects of HIV-1 subtype and ethnicity on the rate of CD4 cell count decline in patients naive to antiretroviral therapy: a Canadian-European collaborative retrospective cohort study. Cmaj Open. 2: E318-29. PMID 25485259 DOI: 10.9778/cmajo.20140017 |
0.427 |
|
| 2014 |
MacParland SA, Bilodeau M, Grebely J, Bruneau J, Cooper C, Klein M, Sagan S, Choucha N, Balfour L, Bialystok F, Krajden M, Raven J, Roberts E, Russell R, Houghton M, et al. The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era. Canadian Journal of Gastroenterology & Hepatology. 28: 481-7. PMID 25314353 DOI: 10.1155/2014/704919 |
0.436 |
|
| 2014 |
Beachler DC, Abraham AG, Silverberg MJ, Jing Y, Fakhry C, Gill MJ, Dubrow R, Kitahata MM, Klein MB, Burchell AN, Korthuis PT, Moore RD, D'Souza G. Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. Oral Oncology. 50: 1169-76. PMID 25301563 DOI: 10.1016/J.Oraloncology.2014.09.011 |
0.315 |
|
| 2014 |
Klein MB, Rollet-Kurhajec KC, Moodie EE, Yaphe S, Tyndall M, Walmsley S, Gill J, Martel-Laferriere V, Cooper C. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). Aids (London, England). 28: 1957-65. PMID 25259703 DOI: 10.1097/Qad.0000000000000377 |
0.466 |
|
| 2014 |
Dieterich D, Rockstroh JK, Orkin C, Gutiérrez F, Klein MB, Reynes J, Shukla U, Jenkins A, Lenz O, Ouwerkerk-Mahadevan S, Peeters M, De La Rosa G, Tambuyzer L, Jessner W. Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 1579-87. PMID 25192745 DOI: 10.1093/Cid/Ciu675 |
0.5 |
|
| 2014 |
Klein MB, Lee T, Brouillette MJ, Sheehan NL, Walmsley S, Wong DK, Conway B, Hull M, Cooper C, Haidar S, Vezina S, Annable L, Young S, Zubyk W, Singer J. Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial. Hiv Clinical Trials. 15: 161-75. PMID 25143025 DOI: 10.1310/Hct1504-161 |
0.46 |
|
| 2014 |
Kared H, Saeed S, Klein MB, Shoukry NH. CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals. Plos One. 9: e101441. PMID 25007250 DOI: 10.1371/Journal.Pone.0101441 |
0.498 |
|
| 2014 |
Bhargava M, Cajas JM, Wainberg MA, Klein MB, Pant Pai N. Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review. Journal of the International Aids Society. 17: 18944. PMID 24998532 DOI: 10.7448/Ias.17.1.18944 |
0.45 |
|
| 2014 |
Yam KK, Gipson E, Klein M, Walmsley S, Haase D, Halperin S, Scheifele D, Ward BJ, Cooper C. High level antibody avidity is achieved in HIV-seropositive recipients of an inactivated split adjuvanted (AS03A) influenza vaccine. Journal of Clinical Immunology. 34: 655-62. PMID 24824648 DOI: 10.1007/S10875-014-0054-Z |
0.368 |
|
| 2014 |
Cooper CL, Klein MB. HIV/hepatitis C virus coinfection management: changing guidelines and changing paradigms. Hiv Medicine. 15: 621-4. PMID 24802099 DOI: 10.1111/Hiv.12161 |
0.561 |
|
| 2014 |
Peters L, Neuhaus J, Duprez D, Neaton JD, Tracy R, Klein MB, Mocroft A, Rockstroh J, Dore G, Lundgren JD. Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 60: 295-300. PMID 24793968 DOI: 10.1016/J.Jcv.2014.03.017 |
0.586 |
|
| 2014 |
Lo Re V, Kallan MJ, Tate JP, Localio AR, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park L, Dubrow R, Reddy KR, et al. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Annals of Internal Medicine. 160: 369-79. PMID 24723077 DOI: 10.7326/M13-1829 |
0.545 |
|
| 2014 |
Schnitzer ME, Moodie EE, van der Laan MJ, Platt RW, Klein MB. Modeling the impact of hepatitis C viral clearance on end-stage liver disease in an HIV co-infected cohort with targeted maximum likelihood estimation. Biometrics. 70: 144-52. PMID 24571372 DOI: 10.1111/Biom.12105 |
0.49 |
|
| 2014 |
Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1449-58. PMID 24569533 DOI: 10.1093/Cid/Ciu097 |
0.495 |
|
| 2014 |
Cox J, Maurais E, Hu L, Moodie EE, Law S, Bozinoff N, Potter M, Rollet K, Hull M, Tyndall M, Cooper C, Gill J, Saeed S, Klein MB. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort. Drug and Alcohol Dependence. 137: 121-8. PMID 24559606 DOI: 10.1016/J.Drugalcdep.2014.01.014 |
0.534 |
|
| 2014 |
Althoff KN, Rebeiro P, Brooks JT, Buchacz K, Gebo K, Martin J, Hogg R, Thorne JE, Klein M, Gill MJ, Sterling TR, Yehia B, Silverberg MJ, Crane H, Justice AC, et al. Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 1185-9. PMID 24463281 DOI: 10.1093/Cid/Ciu044 |
0.444 |
|
| 2014 |
Cescon A, Chan K, Raboud JM, Burchell AN, Forrest JI, Klein MB, Loutfy MR, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Cooper C. Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. Aids (London, England). 28: 121-7. PMID 24413263 DOI: 10.1097/Qad.0000000000000020 |
0.566 |
|
| 2014 |
Palmer AK, Cescon A, Chan K, Cooper C, Raboud JM, Miller CL, Burchell AN, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Loutfy MR. Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. Journal of the International Association of Providers of Aids Care. 13: 56-62. PMID 24309754 DOI: 10.1177/2325957413510606 |
0.45 |
|
| 2014 |
Ndumbi P, Gillis J, Raboud J, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas C. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy. Hiv Medicine. 15: 153-64. PMID 24304582 DOI: 10.1111/Hiv.12096 |
0.36 |
|
| 2014 |
Anderson JP, Tchetgen Tchetgen EJ, Lo Re V, Tate JP, Williams PL, Seage GR, Horsburgh CR, Lim JK, Goetz MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Klein MB, Justice AC. Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 719-27. PMID 24285848 DOI: 10.1093/Cid/Cit779 |
0.576 |
|
| 2014 |
Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Raboud JM. Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada. Journal of the International Association of Providers of Aids Care. 13: 153-9. PMID 23887923 DOI: 10.1177/2325957413495565 |
0.489 |
|
| 2014 |
Young J, Klein MB. Virus subtype, ethnicity and CD4 decline in untreated HIV infection Future Virology. 9: 337-340. DOI: 10.2217/Fvl.14.14 |
0.49 |
|
| 2014 |
Jenabian M, Kema I, Ramirez RP, Saeed S, Rollet K, Vyboh K, Tejada J, Gilmore N, Klein MB, Routy J. Liver fibrosis is strongly associated with an enhanced level of immunosuppressive tryptophan catabolism independently of HCV viremia in ART-treated HIV/HCV co-infected patients Bmc Infectious Diseases. 14: 1-2. DOI: 10.1186/1471-2334-14-S2-O16 |
0.551 |
|
| 2013 |
Ndumbi P, Gillis J, Raboud JM, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas CM. Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort. Aids (London, England). 27: 2863-72. PMID 25119689 DOI: 10.1097/01.Aids.0000432471.84497.Bc |
0.411 |
|
| 2013 |
Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study. Cmaj Open. 1: E106-14. PMID 25077109 DOI: 10.9778/cmajo.20130009 |
0.386 |
|
| 2013 |
Hull M, Klein M, Shafran S, Tseng A, Giguère P, Côté P, Poliquin M, Cooper C. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 24: 217-38. PMID 24489565 DOI: 10.1155/2013/781410 |
0.55 |
|
| 2013 |
Cescon A, Patterson S, Chan K, Palmer AK, Margolese S, Burchell AN, Cooper C, Klein MB, Machouf N, Montaner JS, Tsoukas C, Hogg RS, Raboud JM, Loutfy MR. Gender differences in clinical outcomes among HIV-positive individuals on antiretroviral therapy in Canada: a multisite cohort study. Plos One. 8: e83649. PMID 24391803 DOI: 10.1371/Journal.Pone.0083649 |
0.48 |
|
| 2013 |
Samji H, Cescon A, Hogg RS, Modur SP, Althoff KN, Buchacz K, Burchell AN, Cohen M, Gebo KA, Gill MJ, Justice A, Kirk G, Klein MB, Korthuis PT, Martin J, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. Plos One. 8: e81355. PMID 24367482 DOI: 10.1371/Journal.Pone.0081355 |
0.424 |
|
| 2013 |
Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C. Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis. Plos One. 8: e78548. PMID 24205255 DOI: 10.1371/Journal.Pone.0078548 |
0.323 |
|
| 2013 |
Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Klein MB. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy. Plos One. 8: e77665. PMID 24204912 DOI: 10.1371/Journal.Pone.0077665 |
0.329 |
|
| 2013 |
Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. The Journal of Infectious Diseases. 208: 1240-9. PMID 23904290 DOI: 10.1093/Infdis/Jit373 |
0.47 |
|
| 2013 |
Beauchamp E, Rollet K, Walmsley S, Wong DK, Cooper C, Klein MB. Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1339-42. PMID 23899675 DOI: 10.1093/Cid/Cit491 |
0.444 |
|
| 2013 |
Brunet L, Moodie EE, Rollet K, Cooper C, Walmsley S, Potter M, Klein MB. Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 663-70. PMID 23811492 DOI: 10.1093/Cid/Cit378 |
0.468 |
|
| 2013 |
Loutfy MR, Walmsley SL, Klein MB, Raboud J, Tseng AL, Blitz SL, Pick N, Conway B, Angel JB, Rachlis AR, Gough K, Cohen J, Haase D, Burdge D, Smaill FM, et al. Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study. Bmc Infectious Diseases. 13: 256. PMID 23732043 DOI: 10.1186/1471-2334-13-256 |
0.44 |
|
| 2013 |
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, ... ... Klein MB, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1174-82. PMID 23315317 DOI: 10.1093/Cid/Cit003 |
0.517 |
|
| 2013 |
Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, Saag MS, Rourke SB, Rachlis A, Napravnik S, Moore RD, Klein MB, Kitahata MM, Kirk GD, Hogg RS, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 405-13. PMID 23254153 DOI: 10.1097/Qai.0B013E31828177D7 |
0.515 |
|
| 2013 |
Rebeiro P, Althoff KN, Buchacz K, Gill J, Horberg M, Krentz H, Moore R, Sterling TR, Brooks JT, Gebo KA, Hogg R, Klein M, Martin J, Mugavero M, Rourke S, et al. Retention among North American HIV-infected persons in clinical care, 2000-2008. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 356-62. PMID 23242158 DOI: 10.1097/Qai.0B013E31827F578A |
0.487 |
|
| 2013 |
Klein MB, Rollet KC, Hull M, Cooper C, Walmsley S, Conway B, Pick N. Who needs direct-acting antivirals for HCV? Challenges faced in advancing HCV therapy for HIV-HCV-coinfected individuals. Antiviral Therapy. 18: 717-21. PMID 23211632 DOI: 10.3851/Imp2484 |
0.483 |
|
| 2013 |
Justice AC, Modur SP, Tate JP, Althoff KN, Jacobson LP, Gebo KA, Kitahata MM, Horberg MA, Brooks JT, Buchacz K, Rourke SB, Rachlis A, Napravnik S, Eron J, Willig JH, ... ... Klein M, et al. Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 149-63. PMID 23187941 DOI: 10.1097/Qai.0B013E31827Df36C |
0.48 |
|
| 2013 |
Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, et al. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality. Hiv Medicine. 14: 10-20. PMID 22639840 DOI: 10.1111/J.1468-1293.2012.01028.X |
0.554 |
|
| 2013 |
Coutlée F, Rodrigues-Coutlée S, Munoz M, Mayrand MH, Charest L, Auger M, Marcus M, Burchell A, Klein M, Castro CD, Preziosi H, Pokomandy Ad. 7. High prevalence of human papillomavirus (HPV) infection and high-grade anal intraepithelial neoplasia in HIV-seropositive women, the EVVA study Sexual Health. 10: 573-573. DOI: 10.1071/Shv10N6Ab7 |
0.34 |
|
| 2013 |
Moqueet N, Lisle C, Carter R, Platt R, Hull M, Cooper C, Walmsley S, Potter M, Klein MB. 480 Favourable Il28B Genotypes And Liver Fibrosis In Hiv/Hepatitis C (Hcv) Co-Infected Individuals From The Canadian Co-Infection Cohort Journal of Hepatology. 58. DOI: 10.1016/S0168-8278(13)60482-1 |
0.54 |
|
| 2012 |
Rossi C, Shrier I, Marshall L, Cnossen S, Schwartzman K, Klein MB, Schwarzer G, Greenaway C. Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. Plos One. 7: e44611. PMID 22957088 DOI: 10.1371/Journal.Pone.0044611 |
0.365 |
|
| 2012 |
Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, Gange SJ, Moore RD, Kitahata MM, Gebo KA, Martin J, Justice AC, Horberg MA, Hogg RS, Sterling TR, ... ... Klein MB, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Annals of Internal Medicine. 157: 325-35. PMID 22944874 DOI: 10.7326/0003-4819-157-5-201209040-00005 |
0.526 |
|
| 2012 |
Yaphe S, Bozinoff N, Kyle R, Shivkumar S, Pai NP, Klein M. Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review. Sexually Transmitted Infections. 88: 558-64. PMID 22859499 DOI: 10.1136/Sextrans-2012-050566 |
0.537 |
|
| 2012 |
Hull MW, Rollet K, Moodie EE, Walmsley S, Cox J, Potter M, Cooper C, Pick N, Saeed S, Klein MB. Insulin resistance is associated with progression to hepatic fibrosis in a cohort of HIV/hepatitis C virus-coinfected patients. Aids (London, England). 26: 1789-94. PMID 22739388 DOI: 10.1097/Qad.0B013E32835612Ce |
0.441 |
|
| 2012 |
Pai NP, Kurji J, Singam A, Barick R, Jafari Y, Klein MB, Chhabra S, Shivkumar P. Simultaneous triple point-of-care testing for HIV, syphilis and hepatitis B virus to prevent mother-to-child transmission in India. International Journal of Std & Aids. 23: 319-24. PMID 22648884 DOI: 10.1258/Ijsa.2011.011139 |
0.467 |
|
| 2012 |
Raboud J, Anema A, Su D, Klein MB, Zakaryan A, Swan T, Palmer A, Hosein S, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg RS, Cooper C, et al. Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy. Hiv Clinical Trials. 13: 90-102. PMID 22510356 DOI: 10.1310/Hct1302-90 |
0.563 |
|
| 2012 |
Hull MW, Rollet K, Odueyungbo A, Saeed S, Potter M, Cox J, Cooper C, Gill J, Klein MB. Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1798-805. PMID 22460964 DOI: 10.1093/Cid/Cis289 |
0.446 |
|
| 2012 |
Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, Machouf N, Montaner JSG, Rourke S, Tsoukas C, Hogg B, Raboud J. Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis. The Journal of Infectious Diseases. 205: 1230-1238. PMID 22438396 DOI: 10.1093/Infdis/Jis104 |
0.521 |
|
| 2012 |
Cooper C, Klein M, Walmsley S, Haase D, MacKinnon-Cameron D, Marty K, Li Y, Smith B, Halperin S, Law B, Scheifele D, Phac Cihr Influenza Research Network. High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1(2009) and improved with booster dosing in a randomized trial of HIV-infected adults. Hiv Clinical Trials. 13: 23-32. PMID 22306585 DOI: 10.1310/hct1301-023 |
0.4 |
|
| 2012 |
Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, et al. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 1026-34. PMID 22291097 DOI: 10.1093/Cid/Cir1012 |
0.51 |
|
| 2011 |
Klein MB, Baril JG, Charron MA, Fortin C, Lalonde R, Matte MF, Poliquin M, Talbot A, Therrien R, Tremblay C, Trottier B, Tsarevsky I, Villeneuve JP. Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 22: 88-96. PMID 22942885 DOI: 10.1155/2011/686918 |
0.509 |
|
| 2011 |
Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, ... Klein MB, et al. Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. The Journal of Infectious Diseases. 204: 893-901. PMID 21849286 DOI: 10.1093/Infdis/Jir421 |
0.406 |
|
| 2011 |
Peters L, Neuhaus J, Mocroft A, Soriano V, Rockstroh J, Dore G, Puoti M, Tedaldi E, Clotet B, Kupfer B, Lundgren JD, Klein MB. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study. Antiviral Therapy. 16: 667-75. PMID 21817188 DOI: 10.3851/Imp1815 |
0.505 |
|
| 2011 |
Abraham AG, Lau B, Deeks S, Moore RD, Zhang J, Eron J, Harrigan R, Gill MJ, Kitahata M, Klein M, Napravnik S, Rachlis A, Rodriguez B, Rourke S, Benson C, et al. Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. American Journal of Epidemiology. 174: 727-35. PMID 21813792 DOI: 10.1093/Aje/Kwr141 |
0.382 |
|
| 2011 |
Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR. Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 38-46. PMID 21709570 DOI: 10.1097/Qai.0B013E3182282Cfc |
0.478 |
|
| 2011 |
Lo Re V, Lim JK, Goetz MB, Tate J, Bathulapalli H, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Kidwai F, Brandt C, Dorey-Stein Z, Reddy KR, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiology and Drug Safety. 20: 689-99. PMID 21626605 DOI: 10.1002/Pds.2148 |
0.327 |
|
| 2011 |
Cooper C, Thorne A, Klein M, Conway B, Boivin G, Haase D, Shafran S, Zubyk W, Singer J, Halperin S, Walmsley S. Immunogenicity is not improved by increased antigen dose or booster dosing of seasonal influenza vaccine in a randomized trial of HIV infected adults. Plos One. 6: e17758. PMID 21512577 DOI: 10.1371/Journal.Pone.0017758 |
0.341 |
|
| 2011 |
Cooper C, Kanters S, Klein M, Chaudhury P, Marotta P, Wong P, Kneteman N, Mills EJ. Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. Aids. 25: 777-786. PMID 21412058 DOI: 10.1097/Qad.0B013E328344Febb |
0.517 |
|
| 2011 |
Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, et al. CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology. 140: 2064-73. PMID 21376049 DOI: 10.1053/J.Gastro.2011.02.060 |
0.344 |
|
| 2011 |
Thorpe J, Saeed S, Moodie EE, Klein MB. Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection. Aids (London, England). 25: 967-75. PMID 21330904 DOI: 10.1097/Qad.0B013E3283455E4B |
0.544 |
|
| 2011 |
Church D, Gregson D, Lloyd T, Klein M, Beckthold B, Laupland K, Gill MJ. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. Journal of Clinical Microbiology. 49: 118-24. PMID 21084515 DOI: 10.1128/Jcm.00685-10 |
0.511 |
|
| 2011 |
Cescon A, Cooper C, Chan K, Palmer A, Klein M, Machouf N, Loutfy, Raboud J, Rachlis A, Ding E, Lima V, Montaner J, Rourke S, Smieja M, Tsoukas C, et al. Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort. Hiv Medicine. 12: 352-360. PMID 21059167 DOI: 10.1111/J.1468-1293.2010.00890.X |
0.461 |
|
| 2010 |
Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, et al. CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation? Aids Research and Therapy. 7: 45. PMID 21159161 DOI: 10.1186/1742-6405-7-45 |
0.482 |
|
| 2010 |
Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, et al. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 451-9. PMID 21105259 DOI: 10.1097/Qai.0B013E3181Ec28Ff |
0.383 |
|
| 2010 |
Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA. Virologic and immunologic response to HAART, by age and regimen class. Aids (London, England). 24: 2469-79. PMID 20829678 DOI: 10.1097/Qad.0B013E32833E6D14 |
0.31 |
|
| 2010 |
Rizza SA, Cummins NW, Rider DN, Saeed S, Klein MB, Badley AD. Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals. Aids (London, England). 24: 2639-44. PMID 20802294 DOI: 10.1097/Qad.0B013E32833Eacfd |
0.514 |
|
| 2010 |
Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, ... Klein MB, et al. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. Lancet. 376: 340-5. PMID 20638118 DOI: 10.1016/S0140-6736(10)60932-4 |
0.363 |
|
| 2010 |
Vali B, Jones RB, Sakhdari A, Sheth PM, Clayton K, Yue FY, Gyenes G, Wong D, Klein MB, Saeed S, Benko E, Kovacs C, Kaul R, Ostrowski MA. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. European Journal of Immunology. 40: 2493-505. PMID 20623550 DOI: 10.1002/Eji.201040340 |
0.495 |
|
| 2010 |
Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. Aids (London, England). 24: 1857-65. PMID 20479633 DOI: 10.1097/Qad.0B013E32833Adbb5 |
0.552 |
|
| 2010 |
Althoff KN, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Justice AC, Gebo KA, Eron JJ, Rourke SB, Gill MJ, Rodriguez B, et al. Late presentation for human immunodeficiency virus care in the United States and Canada. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 50: 1512-20. PMID 20415573 DOI: 10.1086/652650 |
0.508 |
|
| 2010 |
Dore GJ, Soriano V, Rockstroh J, Kupfer B, Tedaldi E, Peters L, Neuhaus J, Puoti M, Klein MB, Mocroft A, Clotet B, Lundgren JD. Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption. Aids (London, England). 24: 857-65. PMID 20216301 DOI: 10.1097/Qad.0B013E328334Bddb |
0.498 |
|
| 2010 |
Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walmsley S, Rachlis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS, et al. Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries. Bmc Infectious Diseases. 10: 40. PMID 20184766 DOI: 10.1186/1471-2334-10-40 |
0.452 |
|
| 2010 |
Klein MB, Yang H, DelBalso L, Carbonneau J, Frost E, Boivin G. Viral pathogens including human metapneumovirus are the primary cause of febrile respiratory illness in HIV-infected adults receiving antiretroviral therapy. The Journal of Infectious Diseases. 201: 297-301. PMID 19951142 DOI: 10.1086/649587 |
0.415 |
|
| 2010 |
Klein MB, Saeed S, Yang H, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haase D, Haider S, Montaner J, Pick N, Rachlis A, Rouleau D, et al. Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. International Journal of Epidemiology. 39: 1162-9. PMID 19786463 DOI: 10.1093/Ije/Dyp297 |
0.573 |
|
| 2010 |
D’Souza G, Jing Y, Strickler H, Silverberg M, Engels E, Bosch R, Brooks JT, Dubrow R, Eron J, Gebo K, Gill MJ, Hogg B, Kitahata M, Klein M, Moore R, et al. Cervical Cancer Epidemiology Among HIV-Infected Women in North America Infectious Agents and Cancer. 5: 1-2. DOI: 10.1186/1750-9378-5-S1-A9 |
0.439 |
|
| 2009 |
Brassard P, Hottes TS, Lalonde RG, Klein MB. Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 20: 51-7. PMID 20514160 DOI: 10.1155/2009/658382 |
0.452 |
|
| 2009 |
Deeks SG, Gange SJ, Kitahata MM, Saag MS, Justice AC, Hogg RS, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Benson CA, Collier AC, Martin JN, Klein MB, et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1582-90. PMID 19845473 DOI: 10.1086/644768 |
0.428 |
|
| 2009 |
Martinez-Cajas JL, Pai NP, Klein MB, Wainberg MA. Differences in resistance mutations among HIV-1 non-subtype B infections: a systematic review of evidence (1996-2008). Journal of the International Aids Society. 12: 11. PMID 19566959 DOI: 10.1186/1758-2652-12-11 |
0.37 |
|
| 2009 |
Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, Justice AC, Hogg RS, Deeks SG, Eron JJ, Brooks JT, Rourke SB, Gill MJ, Bosch RJ, Martin JN, Klein MB, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. The New England Journal of Medicine. 360: 1815-26. PMID 19339714 DOI: 10.1056/Nejmoa0807252 |
0.388 |
|
| 2009 |
Keller M, Lu Y, Lalonde RG, Klein MB. Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. Aids (London, England). 23: 731-7. PMID 19279446 DOI: 10.1097/Qad.0B013E328326F77F |
0.472 |
|
| 2009 |
Moodie EE, Pant Pai N, Klein MB. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts. Plos One. 4: e4517. PMID 19223976 DOI: 10.1371/Journal.Pone.0004517 |
0.604 |
|
| 2009 |
Pai NP, Klein MB. Rapid testing at labor and delivery to prevent mother-to-child HIV transmission in developing settings: issues and challenges. Women's Health (London, England). 5: 55-62. PMID 19102641 DOI: 10.2217/17455057.5.1.55 |
0.457 |
|
| 2009 |
Potter M, Klein MB. Co-infections and co-therapies: treatment of HIV in the presence of hepatitis C and hepatitis B Hiv Therapy. 3: 189-207. DOI: 10.2217/17584310.3.2.189 |
0.563 |
|
| 2008 |
Cooper C, Hutton B, Fergusson D, Mills E, Klein MB, Boivin G, Halperin S. A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 19: 419-23. PMID 19436572 DOI: 10.1155/2008/419710 |
0.37 |
|
| 2008 |
Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD. Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study Clinical Infectious Diseases. 47: 1468-1475. PMID 18959492 DOI: 10.1086/593102 |
0.48 |
|
| 2008 |
Pai NP, Barick R, Tulsky JP, Shivkumar PV, Cohan D, Kalantri S, Pai M, Klein MB, Chhabra S. Impact of round-the-clock, rapid oral fluid HIV testing of women in labor in rural India. Plos Medicine. 5: e92. PMID 18462011 DOI: 10.1371/Journal.Pmed.0050092 |
0.475 |
|
| 2008 |
Klein MB, Cooper C, Brouillette M, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, Singer J. CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy. Contemporary Clinical Trials. 29: 617-630. PMID 18262853 DOI: 10.1016/J.Cct.2008.01.001 |
0.468 |
|
| 2008 |
Pai NP, Klein MB. Are we ready for home-based, self-testing for HIV? Future Hiv Therapy. 2: 515-520. DOI: 10.2217/17469600.2.6.515 |
0.423 |
|
| 2008 |
Timm J, Wiese M, Nattermann J, Klein M, Spengler U, Viazov S, Roggendorf M. 121 Impact Of Mhc Class I-Associated Selection Pressure On The Evolution Of Hcv Ns3 In A Single-Source Outbreak Journal of Hepatology. 48. DOI: 10.1016/S0168-8278(08)60123-3 |
0.317 |
|
| 2007 |
Côté P, Baril JG, Hébert MN, Klein M, Lalonde R, Poliquin M, Rouleau D, Therrien R, Vézina S, Willems B, Dion H, Junod P, Lapointe N, Lévesque D, Pinault L, et al. Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie MéDicale / Ammi Canada. 18: 293-303. PMID 18923731 DOI: 10.1155/2007/631054 |
0.546 |
|
| 2007 |
Prior J, Burdge D, Maan E, Milner R, Hankins C, Klein M, Walmsley S. Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 18: 1345-53. PMID 17665239 DOI: 10.1007/S00198-007-0428-7 |
0.357 |
|
| 2007 |
Klein MB, Lu Y, DelBalso L, Coté S, Boivin G. Influenzavirus Infection Is a Primary Cause of Febrile Respiratory Illness in HIV-Infected Adults, Despite Vaccination Clinical Infectious Diseases. 45: 234-240. PMID 17578785 DOI: 10.1086/518986 |
0.434 |
|
| 2007 |
Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB. Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker Journal of Acquired Immune Deficiency Syndromes. 44: 463-469. PMID 17211282 DOI: 10.1097/Qai.0B013E318030Ff8E |
0.746 |
|
| 2006 |
Pai NP, Klein MB. Structured treatment interruptions in chronic HIV management: where next? Expert Review of Anti-Infective Therapy. 4: 909-12. PMID 17181404 DOI: 10.1586/14787210.4.6.909 |
0.508 |
|
| 2006 |
Boulassel MR, Morales R, Murphy T, Lalonde RG, Klein MB. Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons. Journal of Medical Virology. 78: 1158-63. PMID 16847953 DOI: 10.1002/jmv.20676 |
0.617 |
|
| 2006 |
Boulassel MR, Morales R, Murphy T, Lalonde RG, Klein MB. Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons Journal of Medical Virology. 78: 1158-1163. DOI: 10.1002/Jmv.20676 |
0.648 |
|
| 2005 |
Al-Mohri H, Cooper C, Murphy T, Klein M. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus‐coinfected patients Hiv Medicine. 6: 375-378. PMID 16268817 DOI: 10.1111/J.1468-1293.2005.00330.X |
0.703 |
|
| 2005 |
Boulassel, Smith G, Edwardes M, Young M, Klein M, Gilmore N, MacLeod J, LeBlanc R, René P, Allan J, Lalonde R, Routy J. Influence of RANTES, SDF-1 and TGF-beta levels on the value of interleukin-7 as a predictor of virological response in HIV-1-infected patients receiving double boosted protease inhibitor-based therapy. Hiv Medicine. 6: 268-277. PMID 16011532 DOI: 10.1111/J.1468-1293.2005.00306.X |
0.312 |
|
| 2004 |
Willemot P, Klein MB. Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy. Expert Review of Anti-Infective Therapy. 2: 521-32. PMID 15482218 DOI: 10.1586/14787210.2.4.521 |
0.534 |
|
| 2004 |
Klein MB, Willemot P, Murphy T, Lalonde RG. The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection. Aids (London, England). 18: 1895-904. PMID 15353975 DOI: 10.1097/00002030-200409240-00005 |
0.69 |
|
| 2003 |
Boulassel, Smith G, Gilmore N, Klein M, Murphy T, MacLeod J, LeBlanc R, Allan J, René P, Lalonde R, Routy J. Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy. Hiv Medicine. 4: 315-320. PMID 14525542 DOI: 10.1046/J.1468-1293.2003.00165.X |
0.641 |
|
| 2003 |
Klein MB, Lalonde RG, Suissa S. The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes. 33: 365-372. PMID 12843748 DOI: 10.1097/00126334-200307010-00011 |
0.503 |
|
| 2003 |
Klein MB, Campeol N, Lalonde RG, Brenner B, Wainberg MA. Didanosine, interferon-alfa and ribavirin: a highly synergistic combination with potential activity against HIV-1 and hepatitis C virus. Aids (London, England). 17: 1001-8. PMID 12700449 DOI: 10.1097/01.Aids.0000060357.78202.25 |
0.518 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Kronfli N, Dussault C, Klein MB, Lebouché B, Sebastiani G, Cox J. The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort study. Cmaj Open. 7: E674-E679. PMID 31796509 DOI: 10.9778/cmajo.20190068 |
0.295 |
|
| 2019 |
Costiniuk CT, Saneei Z, Salahuddin S, Cox J, Routy JP, Rueda S, Abdallah SJ, Jensen D, Lebouché B, Brouillette MJ, Klein M, Szabo J, Frenette C, Giannakis A, Jenabian MA. Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education. Cannabis and Cannabinoid Research. 4: 204-213. PMID 31579835 DOI: 10.1089/can.2018.0068 |
0.295 |
|
| 2020 |
McClymont E, Coutlée F, Lee M, Albert A, Raboud J, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Yudin MH, Harris M, Wobeser W, Bitnun A, et al. Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living with HIV. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 31917750 DOI: 10.1097/Qai.0000000000002258 |
0.293 |
|
| 2022 |
Kaufman E, Williamson T, Mayrand MH, Burchell AN, Klein M, Charest L, Rodrigues-Coutlée S, Coutlée F, de Pokomandy A. Identifying risk factors for prevalent anal human papillomavirus type 16 infection in women living with HIV. Plos One. 17: e0268521. PMID 35587503 DOI: 10.1371/journal.pone.0268521 |
0.291 |
|
| 2021 |
Park H, Brenner B, Ibanescu RI, Cox J, Weiss K, Klein MB, Hardy I, Narasiah L, Roger M, Kronfli N. Phylogenetic Clustering among Asylum Seekers with New HIV-1 Diagnoses in Montreal, QC, Canada. Viruses. 13. PMID 33915869 DOI: 10.3390/v13040601 |
0.287 |
|
| 2014 |
Moodie EE, Stephens DA, Klein MB. A marginal structural model for multiple-outcome survival data:assessing the impact of injection drug use on several causes of death in the Canadian Co-infection Cohort. Statistics in Medicine. 33: 1409-25. PMID 24272681 DOI: 10.1002/Sim.6043 |
0.284 |
|
| 2015 |
Young J, Moodie EE, Abrahamowicz M, Klein MB, Weber R, Bucher HC. Incomplete Modeling of the Effect of Antiretroviral Therapy on the Risk of Cardiovascular Events. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 26123934 DOI: 10.1093/Cid/Civ515 |
0.282 |
|
| 1997 |
Klein MB, Miller JS, Nelson CM, Goodman JL. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. The Journal of Infectious Diseases. 176: 1405-9. PMID 9359749 DOI: 10.1086/517332 |
0.282 |
|
| 2022 |
Mboumba Bouassa RS, Needham J, Nohynek D, Singer J, Lee T, Bobeuf F, Samarani S, Del Balso L, Paisible N, Vertzagias C, Sebastiani G, Margolese S, Mandarino E, Klein M, Lebouché B, et al. Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028). Biomedicines. 10. PMID 36551926 DOI: 10.3390/biomedicines10123168 |
0.281 |
|
| 2009 |
Martínez-Cajas JL, Pant-Pai N, Klein MB, Wainberg MA. Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence. Aids Reviews. 10: 212-23. PMID 19092977 |
0.277 |
|
| 2022 |
Sebastiani G, Paisible N, Costiniuk C, Cox J, Kablawi D, Klein MB, Kronfli N, Routy JP, Falutz J, Lebouché B, Guaraldi G. The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study. Diagnostics (Basel, Switzerland). 12. PMID 36359434 DOI: 10.3390/diagnostics12112590 |
0.276 |
|
| 2021 |
Engler K, Vicente S, Ma Y, Hijal T, Cox J, Ahmed S, Klein M, Achiche S, Pant Pai N, de Pokomandy A, Lacombe K, Lebouché B. Implementation of an electronic patient-reported measure of barriers to antiretroviral therapy adherence with the Opal patient portal: Protocol for a mixed method type 3 hybrid pilot study at a large Montreal HIV clinic. Plos One. 16: e0261006. PMID 34969046 DOI: 10.1371/journal.pone.0261006 |
0.275 |
|
| 2021 |
McClean AR, Kooij KW, Trigg J, Ye M, Sereda P, McLinden T, Bacani N, Aran N, Thomas R, Wong A, Klein MB, Hull M, Cooper C, Salters K, Hogg RS, et al. Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC). Aids Care. 1-10. PMID 34074181 DOI: 10.1080/09540121.2021.1929813 |
0.275 |
|
| 1998 |
Klein MB, Hayes SF, Goodman JL. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis. Infection and Immunity. 66: 3410-5. PMID 9632613 DOI: 10.1128/Iai.66.7.3410-3415.1998 |
0.274 |
|
| 2023 |
Passos-Castilho AM, Murphy DG, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, Klein MB, Kwong JC, Sander B, Janjua NZ, Greenaway C. A population-based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada. Journal of Viral Hepatitis. PMID 37070269 DOI: 10.1111/jvh.13837 |
0.274 |
|
| 2000 |
Klein MB, Hu S, Chao CC, Goodman JL. The agent of human granulocytic ehrlichiosis induces the production of myelosuppressing chemokines without induction of proinflammatory cytokines. The Journal of Infectious Diseases. 182: 200-5. PMID 10882598 DOI: 10.1086/315641 |
0.274 |
|
| 2024 |
Zhabokritsky A, Klein M, Loutfy M, Guaraldi G, Andany N, Guillemi S, Falutz J, Arbess G, Tan DHS, Walmsley S. Non-AIDS-defining comorbidities impact health related quality of life among older adults living with HIV. Frontiers in Medicine. 11: 1380731. PMID 38690177 DOI: 10.3389/fmed.2024.1380731 |
0.273 |
|
| 1999 |
Goodman JL, Nelson CM, Klein MB, Hayes SF, Weston BW. Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. The Journal of Clinical Investigation. 103: 407-12. PMID 9927502 DOI: 10.1172/Jci4230 |
0.273 |
|
| 2023 |
Munari SC, Traeger MW, Menon V, Latham NH, Manoharan L, Luhmann N, Baggaley R, MacDonald V, Verster A, Siegfried N, Conway B, Klein M, Bruneau J, Stoové MA, Hellard ME, et al. Determining reinfection rates by hepatitis C testing interval among key populations: A systematic review and meta-analysis. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 37817387 DOI: 10.1111/liv.15705 |
0.272 |
|
| 2022 |
Muiru AN, Madden E, Scherzer R, Horberg MA, Silverberg MJ, Klein MB, Mayor AM, Gill MJ, Napravnik S, Crane HM, Marconi VC, Koethe JR, Abraham AG, Althoff KN, Lucas GM, et al. Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 36069064 DOI: 10.1093/cid/ciac731 |
0.272 |
|
| 2016 |
Kyle RP, Moodie EE, Klein MB, Abrahamowicz M. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models. American Journal of Epidemiology. PMID 27416840 DOI: 10.1093/Aje/Kww068 |
0.272 |
|
| 2014 |
Sebastiani G, Ghali P, Wong P, Klein MB, Deschenes M, Myers RP. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey. Canadian Journal of Gastroenterology & Hepatology. 28: 23-30. PMID 24416739 DOI: 10.1155/2014/675409 |
0.272 |
|
| 2020 |
Sangaré MN, Baril JG, de Pokomandy A, Laprise C, Deshaies C, Klein M, Thomas R, Tremblay C, Roger M, Pexos C, Greenwald Z, Machouf N, Durand M, Hardy I, Dakouo M, et al. Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV. Medicine. 99: e23335. PMID 33217873 DOI: 10.1097/MD.0000000000023335 |
0.268 |
|
| 2022 |
McClymont E, Albert AY, Wang C, Dos Santos SJ, Coutlée F, Lee M, Walmsley S, Lipsky N, Loutfy M, Trottier S, Smaill F, Klein MB, Yudin MH, Harris M, Wobeser W, et al. Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV. International Journal of Std & Aids. 9564624221109686. PMID 35775280 DOI: 10.1177/09564624221109686 |
0.266 |
|
| 2023 |
Snell G, Marshall AD, van Gennip J, Bonn M, Butler-McPhee J, Cooper CL, Kronfli N, Williams S, Bruneau J, Feld JJ, Janjua NZ, Klein M, Cunningham N, Grebely J, Bartlett SR. Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study. Canadian Liver Journal. 6: 190-200. PMID 37503523 DOI: 10.3138/canlivj-2022-0040 |
0.259 |
|
| 2019 |
Kyle RP, Moodie EEM, Klein MB, Abrahamowicz M. Evaluating Flexible Modeling of Continuous Covariates in Inverse Weighted Estimators. American Journal of Epidemiology. PMID 30649165 DOI: 10.1093/Aje/Kwz004 |
0.258 |
|
| 1997 |
Klein MB, Nelson CM, Goodman JL. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins. Antimicrobial Agents and Chemotherapy. 41: 76-9. PMID 8980758 DOI: 10.1128/Aac.41.1.76 |
0.254 |
|
| 2022 |
Feld JJ, Klein MB, Rahal Y, Lee SS, Mohammed S, King A, Smyth D, Gonzalez YS, Nugent A, Janjua NZ. Timing of elimination of hepatitis C virus in Canada's provinces. Canadian Liver Journal. 5: 493-506. PMID 38144411 DOI: 10.3138/canlivj-2022-0003 |
0.25 |
|
| 2011 |
Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, Machouf N, Montaner J, Rourke SB, Smieja M, Tsoukas C, Yip B, Milan D, Hogg RS. Cohort profile: the Canadian Observational Cohort collaboration. International Journal of Epidemiology. 40: 25-32. PMID 20157000 DOI: 10.1093/Ije/Dyp393 |
0.246 |
|
| 2023 |
Lam C, Landry S, Moussa G, Sakr D, Varinot G, Mousseau K, Martel D, Frenette AJ, Ambaraghassi G, Rouleau D, Cantarovich M, Klein MB, Sheehan NL, Lemire B. Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review. Transplantation Direct. 9: e1441. PMID 36733439 DOI: 10.1097/TXD.0000000000001441 |
0.245 |
|
| 2025 |
Davy-Mendez T, Napravnik S, Hogan BC, Eron JJ, Gebo KA, Althoff KN, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Colasanti JA, Nijhawan A, Karris MY, Klein MB, Lang R, et al. Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 40178532 DOI: 10.1093/cid/ciaf167 |
0.239 |
|
| 2015 |
Saarela O, Stephens DA, Moodie EE, Klein MB. On Bayesian estimation of marginal structural models. Biometrics. 71: 279-88. PMID 25677103 DOI: 10.1111/Biom.12269 |
0.238 |
|
| 2024 |
Passos-Castilho AM, Murphy DG, Blouin K, Benedetti A, Panagiotoglou D, Bruneau J, Klein MB, Kwong JC, Sander B, Janjua NZ, Greenaway C. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study. Viruses. 16. PMID 38543755 DOI: 10.3390/v16030389 |
0.237 |
|
| 2021 |
Davy-Mendez T, Napravnik S, Eron JJ, Cole SR, van Duin D, Wohl DA, Hogan BC, Althoff KN, Gebo KA, Moore RD, Silverberg MJ, Horberg MA, Gill MJ, Mathews WC, Klein MB, et al. Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. The Journal of Infectious Diseases. 224: 657-666. PMID 34398239 DOI: 10.1093/infdis/jiaa786 |
0.233 |
|
| 2000 |
Behl R, Klein MB, Dandelet L, Bach RR, Goodman JL, Key NS. Induction of Tissue Factor Procoagulant Activity in Myelomonocytic Cells Inoculated by the Agent of Human Granulocytic Ehrlichiosis Thrombosis and Haemostasis. 83: 114-118. DOI: 10.1055/S-0037-1613766 |
0.227 |
|
| 1997 |
Klein MB, Lalonde RG. The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis Clinical Infectious Diseases. 24: 522-523. PMID 9114218 DOI: 10.1093/Clinids/24.3.522 |
0.222 |
|
| 2019 |
Linthwaite B, Cox J, Klein MB, Peiris H, Salahuddin S, Routy J, Lebouché B, Brouillette M, Szabo J, Giannakis A, LeBlanc R, Gilman S, Costiniuk CT. Use of Smoking Cessation Aids in a Convenience Sample of PLHIV in a Canadian Tertiary Care Clinic The Open Aids Journal. 13: 1-6. DOI: 10.2174/1874613601913010001 |
0.222 |
|
| 1999 |
Weston BW, Hiller KM, Mayben JP, Manousos G, Nelson CM, Klein MB, Goodman JL. A cloned CD15s-negative variant of HL60 cells is deficient in expression of FUT7 and does not adhere to cytokine-stimulated endothelial cells. European Journal of Haematology. 63: 42-9. PMID 10414454 DOI: 10.1111/J.1600-0609.1999.Tb01849.X |
0.221 |
|
| 2018 |
Chan J, Young J, Cox J, Nitulescu R, Klein MB. Patterns of practice and barriers to care for hepatitis C in the direct-acting antiviral (DAA) era: A national survey of Canadian infectious diseases physicians. Canadian Liver Journal. 1: 231-239. PMID 35992622 DOI: 10.3138/canlivj.2018-0012 |
0.212 |
|
| 2022 |
Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V, Boesecke C, Vandekerckhove L, Yakubovsky M, Sendagorta E, ... ... Klein MB, et al. Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022. The New England Journal of Medicine. PMID 35866746 DOI: 10.1056/NEJMoa2207323 |
0.21 |
|
| 2022 |
Klein MB. Simplifying HCV treatment: a pathway to elimination and model for delivering health care to vulnerable populations. The Lancet. Gastroenterology & Hepatology. 7: 277-279. PMID 35026143 DOI: 10.1016/S2468-1253(21)00467-2 |
0.207 |
|
| 2007 |
Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, ... ... Klein MB, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). International Journal of Epidemiology. 36: 294-301. PMID 17213214 DOI: 10.1093/Ije/Dyl286 |
0.204 |
|
| 2008 |
Keller M, Mak A, Thibert L, Rene P, Klein MB. Mycobacterium haemophilum Epididymal Abscess in a Renal Transplant Patient Journal of Clinical Microbiology. 46: 2459-2460. PMID 18508938 DOI: 10.1128/Jcm.00735-08 |
0.204 |
|
| 2014 |
Hull M, Giguère P, Klein M, Shafran S, Tseng A, Côté P, Poliquin M, Cooper C. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale / Ammi Canada. 25: 39-62. PMID 24634688 DOI: 10.1155/2014/921314 |
0.204 |
|
| 2011 |
Young J, Klein MB, Ledergerber B. Noncirrhotic portal hypertension and didanosine: a re-analysis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 154-5. PMID 21148537 DOI: 10.1093/Cid/Ciq079 |
0.203 |
|
| 2018 |
Saeed S, Moodie EEM, Strumpf EC, Klein MB. Segmented generalized mixed effect models to evaluate health outcomes. International Journal of Public Health. PMID 29549396 DOI: 10.1007/S00038-018-1091-9 |
0.202 |
|
| 2024 |
Kronfli N, Mambro A, Riback LR, Ortiz-Paredes D, Dussault C, Chalifoux S, Del Balso L, Petropoulos A, Lim M, Halavrezos A, Sebastiani G, Klein MB, Lebouche B, Cox J, Akiyama MJ. Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada. The International Journal On Drug Policy. 133: 104624. PMID 39426103 DOI: 10.1016/j.drugpo.2024.104624 |
0.202 |
|
| 2021 |
Young J, Lo Re V, Kim HN, Sterling TR, Althoff KN, Gebo KA, Gill MJ, Horberg MA, Mayor AM, Moore RD, Silverberg MJ, Klein MB. Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD. Pharmacoepidemiology and Drug Safety. PMID 34729853 DOI: 10.1002/pds.5379 |
0.202 |
|
| 2006 |
Mayo NE, Brophy J, Goldberg MS, Klein MB, Miller S, Platt RW, Ritchie J. Peering at peer review revealed high degree of chance associated with funding of grant applications. Journal of Clinical Epidemiology. 59: 842-8. PMID 16828678 DOI: 10.1016/J.Jclinepi.2005.12.007 |
0.201 |
|
| 2019 |
Saeed S, Moodie EEM, Strumpf EC, Klein MB. Evaluating the impact of health policies: using a difference-in-differences approach. International Journal of Public Health. PMID 30607473 DOI: 10.1007/S00038-018-1195-2 |
0.194 |
|
| 2015 |
Saarela O, Stephens DA, Moodie EE, Klein MB. Rejoinder "On Bayesian estimation of marginal structural models". Biometrics. 71: 299-301. PMID 25652412 DOI: 10.1111/Biom.12274 |
0.192 |
|
| 2013 |
Rossi C, Schwartzman K, Oxlade O, Klein MB, Greenaway C. Tornado diagram for one-way deterministic sensitivity analysis. Plos One. DOI: 10.1371/Journal.Pone.0078548.G005 |
0.179 |
|
| 2022 |
Rodriguez Duque D, Stephens DA, Moodie EEM, Klein MB. Semiparametric Bayesian inference for optimal dynamic treatment regimes via dynamic marginal structural models. Biostatistics (Oxford, England). PMID 35385100 DOI: 10.1093/biostatistics/kxac007 |
0.179 |
|
| 2025 |
Fontaine G, Taylor N, Bruneau J, Kronfli N, Greenaway C, Biondi MJ, Klein MB, Saeed S, Grebely J, Presseau J. The urgent need for implementation science to achieve hepatitis C elimination. The Lancet. Gastroenterology & Hepatology. PMID 40054488 DOI: 10.1016/S2468-1253(25)00050-0 |
0.178 |
|
| 2013 |
Hull MW, Rollet K, Klein MB. Reply to Mandorfer et al. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 905-6. PMID 23243174 DOI: 10.1093/Cid/Cis1036 |
0.169 |
|
| 2005 |
Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, Klein MB, Lalonde R, Piché A, Hankins CA. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001. Aids (London, England). 18: 2411-8. PMID 15622317 |
0.135 |
|
| 2015 |
Greenaway C, Ma AT, Kloda LA, Klein M, Cnossen S, Schwarzer G, Shrier I. Correction: The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis. Plos One. 10: e0144567. PMID 26650678 DOI: 10.1371/journal.pone.0144567 |
0.121 |
|
| 2022 |
Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, Costiniuk C, Daley P, Daneman N, Douglas J, Downey C, ... ... Klein M, et al. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. PMID 35045989 DOI: 10.1503/cmaj.211698 |
0.099 |
|
| 2023 |
Turchetta A, Savy N, Stephens DA, Moodie EEM, Klein MB. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies. Statistics in Medicine. PMID 37491664 DOI: 10.1002/sim.9855 |
0.099 |
|
| 2024 |
Ma Y, Lessard D, Vicente S, Engler K, Rodriguez Cruz A, Laymouna M, Hijal T, Del Balso L, Thériault G, Paisible N, Kronfli N, Pomey MP, Peiris H, Barkati S, Brouillette MJ, ... Klein M, et al. Implementing a Patient Portal for the Remote Follow-Up of Self-Isolating Patients With COVID-19 Infection Through Patient and Stakeholder Engagement (the Opal-COVID Study): Mixed Methods Pilot Study. Journal of Participatory Medicine. 16: e48194. PMID 39631058 DOI: 10.2196/48194 |
0.096 |
|
| 2022 |
Harrison LB, Bergeron G, Cadieux G, Charest H, Fafard J, Levade I, Blais AC, Huchet E, Trottier B, Vlad D, Szabo J, Thomas R, Poulin S, Greenaway C, Zaharatos GJ, ... ... Klein MB, et al. Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak. Annals of Internal Medicine. PMID 36508736 DOI: 10.7326/M22-2699 |
0.084 |
|
| 2022 |
Klein MB, Young J. Can integrase inhibitors reduce mortality? The Lancet. Hiv. 9: e371-e372. PMID 35659330 DOI: 10.1016/S2352-3018(22)00103-5 |
0.072 |
|
| Hide low-probability matches. |